<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">56656</article-id><article-id pub-id-type="doi">10.7554/eLife.56656</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>SKAP2 is required for defense against <italic>K. pneumoniae</italic> infection and neutrophil respiratory burst</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-178339"><name><surname>Nguyen</surname><given-names>Giang T</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8967-3396</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178340"><name><surname>Shaban</surname><given-names>Lamyaa</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94368"><name><surname>Mack</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178341"><name><surname>Swanson</surname><given-names>Kenneth D</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-7078"><name><surname>Bunnell</surname><given-names>Stephen C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6887-0828</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178342"><name><surname>Sykes</surname><given-names>David B</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-177827"><name><surname>Mecsas</surname><given-names>Joan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9455-6672</contrib-id><email>joan.mecsas@tufts.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Graduate Program in Immunology, Tufts Graduate School of Biomedical Sciences</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Graduate Program in Molecular Microbiology, Tufts Graduate School of Biomedical Sciences</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Internal Medicine II, University Hospital Regensburg</institution><addr-line><named-content content-type="city">Regensburg</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution>Brain Tumor Center and Neuro-Oncology Unit, Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Department of Immunology, School of Medicine, Tufts University</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Center for Regenerative Medicine, Massachusetts General Hospital</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution>Department of Molecular Biology and Microbiology, School of Medicine, Tufts University</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Stallings</surname><given-names>Christina L</given-names></name><role>Reviewing Editor</role><aff><institution>Washington University School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>van der Meer</surname><given-names>Jos WM</given-names></name><role>Senior Editor</role><aff><institution>Radboud University Medical Centre</institution><country>Netherlands</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>30</day><month>04</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e56656</elocation-id><history><date date-type="received" iso-8601-date="2020-03-05"><day>05</day><month>03</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-04-29"><day>29</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Nguyen et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Nguyen et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-56656-v2.pdf"/><abstract><p><italic>Klebsiella pneumoniae</italic> is a respiratory, blood, liver, and bladder pathogen of significant clinical concern. We show that the adaptor protein, SKAP2, is required for protection against <italic>K. pneumoniae</italic> (ATCC 43816) pulmonary infections. <italic>Skap2-/</italic>- mice had 100-fold higher bacterial burden when compared to wild-type and burden was controlled by SKAP2 expression in innate immune cells. <italic>Skap2-/</italic>- neutrophils and monocytes were present in infected lungs, and the neutrophils degranulated normally in response to <italic>K. pneumoniae</italic> infection in mice; however, <italic>K. pneumoniae</italic>-stimulated reactive oxygen species (ROS) production in vitro was abolished. <italic>K. pneumoniae</italic>-induced neutrophil ROS response required the activity of SFKs, Syk, Btk, PLCγ2, and PKC. The loss of SKAP2 significantly hindered the <italic>K. pneumoniae</italic>-induced phosphorylation of SFKs, Syk, and Pyk2 implicating SKAP2 as proximal to their activation in pathogen-signaling pathways. In conclusion, SKAP2-dependent signaling in neutrophils is essential for <italic>K. pneumoniae</italic>-activated ROS production and for promoting bacterial clearance during infection.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p><italic>Klebsiella pneumoniae</italic> is a type of bacteria that can cause life-threatening infections – including pneumonia, blood stream infections, and urinary tract infections – in hospitalized patients. These infections can be difficult to treat because some <italic>K. pneumoniae</italic> are resistant to antibiotics. The bacteria are normally found in the human intestine, and they do not usually cause infections in healthy people. This implies that healthy people’s immune systems are better able to fend off <italic>K. pneumoniae</italic> infections; learning how could help scientists develop new ways to treat or prevent infections in hospitalized patients.</p><p>In healthy people, a type of immune cell called neutrophils are the first line of defense against bacterial infections. Several different proteins are needed to activate neutrophils, including a protein called SKAP2. But the role of this protein in fighting <italic>K. pneumoniae</italic> infections is not clear.</p><p>To find out what role SKAP2 plays in the defense against pneumonia caused by <italic>K. pneumoniae,</italic> Nguyen et al. compared infections in mice with and without the protein. Mice lacking SKAP2 in their white blood cells had more bacteria in their lungs than normal mice. The experiments showed that neutrophils from mice with SKAP2 produce a burst of chemicals called “reactive oxygen species”, which can kill bacteria. But neutrophils without the protein do not. Without SKAP2, several proteins that help produce reactive oxygen species do not work.</p><p>Understanding the role of SKAP2 in fighting infections may help scientists better understand the immune system. This could help clinicians to treat conditions that cause it to be hyperactive or ineffective. More studies are needed to determine if SKAP2 works the same way in human neutrophils and if it works against all types of <italic>K. pneumoniae</italic>. If it does, then scientists might be able use this information to develop therapies that help the immune system fight infections.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd><italic>Klebsiella pneumoniae</italic></kwd><kwd>neutrophils</kwd><kwd>bacterial pneumonia</kwd><kwd>reactive oxygen species</kwd><kwd>SKAP2</kwd><kwd>Hoxb8</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 AI113166</award-id><principal-award-recipient><name><surname>Mecsas</surname><given-names>Joan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>4T32AI007422</award-id><principal-award-recipient><name><surname>Shaban</surname><given-names>Lamyaa</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>SKAP2 is critical for hematopoietic cell protection against <italic>Klebsiella</italic> infection in mouse lungs, for full phosphorylation of Src Family Kinases, Syk, and Pyk2, and for <italic>Klebsiella</italic>-induced reactive oxygen species production.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p><italic>Klebsiella pneumoniae</italic> is an opportunistic Gram-negative pathogen that can cause a wide range of life-threatening infections, including pneumonia, sepsis and urinary tract infections (<xref ref-type="bibr" rid="bib8">Bengoechea and Sa Pessoa, 2019</xref>; <xref ref-type="bibr" rid="bib73">Paczosa and Mecsas, 2016</xref>; <xref ref-type="bibr" rid="bib26">European Centre for Disease Prevention and Control, 2018</xref>; <xref ref-type="bibr" rid="bib101">Weiner et al., 2016</xref>). <italic>K. pneumoniae</italic> is a leading cause of hospital-associated infections with one recent study reporting that <italic>K. pneumoniae</italic> contributes to 7.7% of cases from over 4500 hospitals (<xref ref-type="bibr" rid="bib101">Weiner et al., 2016</xref>). The increasing number of severe, and sometimes systemic, <italic>K. pneumoniae</italic> infections are largely attributed to a rise in antibiotic-resistant strains (<xref ref-type="bibr" rid="bib28">Falagas et al., 2014</xref>; <xref ref-type="bibr" rid="bib26">European Centre for Disease Prevention and Control, 2018</xref>; <xref ref-type="bibr" rid="bib48">Kobayashi et al., 2016</xref>) and hypervirulent strains that generate thicker capsules (<xref ref-type="bibr" rid="bib107">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="bib41">Harada et al., 2019</xref>; <xref ref-type="bibr" rid="bib51">Lam et al., 2018</xref>). Highlighting the importance of the innate immune response, neutropenic patients are highly susceptible to life-threatening respiratory and bloodstream infections, including those caused by <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="bib110">Zhu et al., 2018</xref>; <xref ref-type="bibr" rid="bib62">Micozzi et al., 2017</xref>). <italic>K. pneumoniae</italic> lung pathogenesis has been extensively investigated in a mouse model using the rodent-adapted ATCC 43816 (<xref ref-type="bibr" rid="bib8">Bengoechea and Sa Pessoa, 2019</xref>; <xref ref-type="bibr" rid="bib52">Lawlor et al., 2005</xref>; <xref ref-type="bibr" rid="bib103">Xiong et al., 2015</xref>; <xref ref-type="bibr" rid="bib3">Bachman et al., 2015</xref>; <xref ref-type="bibr" rid="bib97">Vornhagen et al., 2019</xref>; <xref ref-type="bibr" rid="bib7">Batra et al., 2012</xref>). In murine models of infection, the <italic>K. pneumoniae</italic> 43816 strain robustly infects lungs eliciting a strong innate immune response through rapid and concurrent recruitment of neutrophils and iMOs to the infected lungs (<xref ref-type="bibr" rid="bib52">Lawlor et al., 2005</xref>; <xref ref-type="bibr" rid="bib103">Xiong et al., 2015</xref>; <xref ref-type="bibr" rid="bib15">Cai et al., 2010</xref>; <xref ref-type="bibr" rid="bib7">Batra et al., 2012</xref>; <xref ref-type="bibr" rid="bib83">Sharma et al., 2014</xref>; <xref ref-type="bibr" rid="bib105">Ye et al., 2001</xref>). Work using this strain has revealed several genes that protect <italic>K. pneumoniae</italic> against the host neutrophil response (<xref ref-type="bibr" rid="bib72">Paczosa et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Silver et al., 2019</xref>).</p><p>Neutrophils are the first responder cell type for fighting against invading pathogens, however, their activation is tightly regulated to prevent severe tissue damage that have been correlated with several autoimmune and inflammatory diseases (<xref ref-type="bibr" rid="bib67">Mócsai, 2013</xref>). At the site of infection, neutrophils can bind to pathogens leading to the activation of various killing mechanisms, including phagocytosis, generation of reactive oxygen species (ROS), degranulation, and release of neutrophil extracellular traps (NETs) (<xref ref-type="bibr" rid="bib32">Futosi et al., 2013</xref>; <xref ref-type="bibr" rid="bib70">Nguyen et al., 2017</xref>; <xref ref-type="bibr" rid="bib67">Mócsai, 2013</xref>). Although the <italic>K. pneumoniae</italic> capsule decreases bacterial binding and internalization (<xref ref-type="bibr" rid="bib80">Regueiro et al., 2006</xref>; <xref ref-type="bibr" rid="bib58">March et al., 2013</xref>), ROS, degranulation, NETs, and cytokine production have all been implicated in host defense against <italic>K. pneumoniae</italic> (<xref ref-type="bibr" rid="bib8">Bengoechea and Sa Pessoa, 2019</xref>; <xref ref-type="bibr" rid="bib17">Chen et al., 2016</xref>; <xref ref-type="bibr" rid="bib42">Hirche et al., 2005</xref>; <xref ref-type="bibr" rid="bib45">Ivin et al., 2017</xref>; <xref ref-type="bibr" rid="bib72">Paczosa et al., 2020</xref>; <xref ref-type="bibr" rid="bib74">Papayannopoulos et al., 2010</xref>; <xref ref-type="bibr" rid="bib108">Zhao et al., 2015</xref>). The importance of ROS in host protection is highlighted in the setting of Chronic Granulomatous Disease (CGD), a disease characterized by genetic mutations in the NADPH oxidase, where patients are unable to make ROS and are susceptible to <italic>Klebsiella</italic> infections (<xref ref-type="bibr" rid="bib102">Wolach et al., 2017</xref>; <xref ref-type="bibr" rid="bib11">Bortoletto et al., 2015</xref>). Furthermore, mice with defective ROS production (<italic>Cybb-/-</italic>) have a higher bacterial burden than wild-type mice during <italic>K. pneumoniae</italic> lung infection (<xref ref-type="bibr" rid="bib72">Paczosa et al., 2020</xref>).</p><p>Receptor-mediated ROS production in neutrophils is driven by signal-transduction pathways that activate components of the NADPH oxidase complex (<xref ref-type="bibr" rid="bib70">Nguyen et al., 2017</xref>; <xref ref-type="bibr" rid="bib32">Futosi et al., 2013</xref>). These signaling pathways are tightly regulated to prevent inappropriate activation and subsequent tissue damage (<xref ref-type="bibr" rid="bib32">Futosi et al., 2013</xref>). Work in mice suggests that signaling through integrin, mincle receptors, G-protein couple receptors (GPCRs) and toll-like receptors (TLRs) are critical for protection against <italic>K. pneumoniae</italic> infection (<xref ref-type="bibr" rid="bib91">Teng et al., 2016</xref>; <xref ref-type="bibr" rid="bib83">Sharma et al., 2014</xref>; <xref ref-type="bibr" rid="bib84">Sharma et al., 2017</xref>; <xref ref-type="bibr" rid="bib80">Regueiro et al., 2006</xref>; <xref ref-type="bibr" rid="bib33">Galvão et al., 2018</xref>; <xref ref-type="bibr" rid="bib8">Bengoechea and Sa Pessoa, 2019</xref>). In fact, multiple receptors may sense and/or bind to <italic>K. pneumoniae</italic> triggering ROS production. Prior studies have indicated a critical role for Src Kinase Associated Phosphoprotein-2, SKAP2 (SKAP-Hom and SKAP-55R) downstream of integrin, and GPCRs in neutrophils and macrophages (<xref ref-type="bibr" rid="bib10">Boras et al., 2017</xref>; <xref ref-type="bibr" rid="bib2">Alenghat et al., 2012</xref>; <xref ref-type="bibr" rid="bib89">Swanson et al., 2008</xref>; <xref ref-type="bibr" rid="bib90">Tanaka et al., 2016</xref>; <xref ref-type="bibr" rid="bib65">Mócsai et al., 2002</xref>; <xref ref-type="bibr" rid="bib93">Togni et al., 2005</xref>). SKAP2, a cytosolic adaptor protein, is required for integrin-mediated ROS production, adhesion, and migration to sterile inflammatory sites through its interaction with mediators of actin rearrangement (<xref ref-type="bibr" rid="bib2">Alenghat et al., 2012</xref>; <xref ref-type="bibr" rid="bib10">Boras et al., 2017</xref>; <xref ref-type="bibr" rid="bib86">Shimamura et al., 2013</xref>; <xref ref-type="bibr" rid="bib90">Tanaka et al., 2016</xref>). SKAP2 is also a target for inactivation by bacterial virulence factors, suggesting that it plays a key role in host defenses against infections (<xref ref-type="bibr" rid="bib9">Black et al., 2000</xref>; <xref ref-type="bibr" rid="bib81">Rolán et al., 2013</xref>). In humans, the <italic>Skap2</italic> gene has been identified as a risk locus for Type 1 Diabetes, and Crohn’s disease (<xref ref-type="bibr" rid="bib46">Jostins et al., 2012</xref>; <xref ref-type="bibr" rid="bib6">Barrett et al., 2009</xref>). In resting cells, SKAP2 is thought to exist in an autoinhibitory conformation as a homodimer that is constitutively bound to PRAM-1 in neutrophils (<xref ref-type="bibr" rid="bib68">Moog-Lutz et al., 2001</xref>; <xref ref-type="bibr" rid="bib81">Rolán et al., 2013</xref>), or its homolog, ADAP, in other immune cells (<xref ref-type="bibr" rid="bib53">Liu et al., 1998</xref>; <xref ref-type="bibr" rid="bib59">Marie-Cardine et al., 1998</xref>; <xref ref-type="bibr" rid="bib9">Black et al., 2000</xref>; <xref ref-type="bibr" rid="bib71">Ophir et al., 2013</xref>). Upon receptor activation, SKAP2 changes to an active conformation that is localized to the plasma membrane, which allows it to interact other effector proteins including Src Family Kinases (SFKs) (<xref ref-type="bibr" rid="bib14">Bureau et al., 2018</xref>; <xref ref-type="bibr" rid="bib59">Marie-Cardine et al., 1998</xref>; <xref ref-type="bibr" rid="bib53">Liu et al., 1998</xref>). In addition, activated SKAP proteins can relay information from receptors to focal adhesion kinases (FAK1/Pyk2) to other cytoskeletal mediators (<xref ref-type="bibr" rid="bib60">Ménasché et al., 2007</xref>; <xref ref-type="bibr" rid="bib10">Boras et al., 2017</xref>; <xref ref-type="bibr" rid="bib90">Tanaka et al., 2016</xref>; <xref ref-type="bibr" rid="bib78">Raab et al., 2017</xref>; <xref ref-type="bibr" rid="bib71">Ophir et al., 2013</xref>).</p><p>Using a murine model of <italic>K. pneumoniae</italic> 43816 infection, we characterized the role of SKAP2 in pulmonary host defense against <italic>K. pneumoniae</italic> in this study. We demonstrate that SKAP2-expressing neutrophils contributed to the pulmonary containment of <italic>K. pneumoniae</italic> in lungs independent of inflammatory monocytes. Using murine neutrophils, we show that <italic>K. pneumoniae</italic>-induced ROS production requires SKAP2, SFKs, Syk, PLCγ, Btk, and PKC, and that SKAP2 is required for maximal <italic>K. pneumoniae</italic>-activated phosphorylation of the tyrosine kinases SFKs, Syk, and Pyk2.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title><italic>Skap2-/</italic>- mice are highly susceptible to pneumonic <italic>K. pneumoniae</italic> infection</title><p>To examine the role of SKAP2 in the pathogenesis of pneumonic <italic>K. pneumoniae</italic> infection, we intranasally infected wild-type (WT) BALB/c or BALB/c <italic>Skap2-/</italic>- mice with a streptomycin-resistant derivative of <italic>K. pneumoniae</italic> 43816, a hyper-capsule producer that belongs to one of the most common hypervirulent serotype, K2 (<xref ref-type="bibr" rid="bib73">Paczosa and Mecsas, 2016</xref>; <xref ref-type="bibr" rid="bib72">Paczosa et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Silver et al., 2019</xref>). Previous studies using <italic>K. pneumoniae</italic> 43816 or a derivative of this strain have reported a 50% lethal dose at 48 hr after infection with 3−5 × 10<sup>3</sup> colony forming units (cfu) in BALB/c mice, and a robust infection with high bacterial burden and cellular infiltration in the lungs by 24 hr with mice developing disseminated infection by 48 hr in C57BL/6J (<xref ref-type="bibr" rid="bib52">Lawlor et al., 2005</xref>; <xref ref-type="bibr" rid="bib103">Xiong et al., 2015</xref>; <xref ref-type="bibr" rid="bib105">Ye et al., 2001</xref>; <xref ref-type="bibr" rid="bib29">Feldman et al., 2019</xref>). WT and <italic>Skap2-/</italic>- mice were infected with 5 × 10<sup>3</sup> cfu and were monitored for weight loss, bacterial colonization, and innate cell recruitment at 8, 16, and 24 hr post infection (hpi) (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A,E–J</xref>). Consistent with prior studies, by 24 hr, infected WT mice lost 2% of their body weight, and <italic>K. pneumoniae</italic> reached on average 10<sup>6</sup> cfu with a 5-fold increase in neutrophil presence in the infected lungs (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib103">Xiong et al., 2015</xref>). However, <italic>Skap2-/</italic>- mice lost significantly more body weight than the WT cohort at 24 hpi (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) and had significantly higher bacterial loads in their lungs at 16 and 24 hpi (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), indicating that <italic>Skap2-/</italic>- mice are less competent at controlling <italic>K. pneumoniae</italic> infection. The increase in bacterial burden did not appear to be due to differences in the numbers of neutrophils (CD11b<sup>+</sup> Ly6G<sup>hi</sup>) because neutrophils were detected at comparable levels in WT and <italic>Skap2-/</italic>- lungs, bone marrow as well as bronchoalveolar lavage of infected mice (<xref ref-type="fig" rid="fig1">Figure 1C</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–D</xref>). In addition, there was no difference in alveolar macrophages (CD11b<sup>int</sup> CD11c<sup>hi</sup>), resident monocytes (CD11b<sup>+</sup> Gr1<sup>lo</sup>), or dendritic cells (CD11b<sup>hi</sup> CD11c<sup>hi</sup>) in the lungs of <italic>K. pneumoniae</italic>-infected WT and <italic>Skap2-/</italic>- mice (<xref ref-type="fig" rid="fig1">Figure 1C</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E–J</xref>). Histological examination showed extensive leukocyte infiltration in both the WT and <italic>Skap2-/</italic>- infected lungs supporting the flow cytometry data (<xref ref-type="fig" rid="fig1">Figure 1D–L</xref>, black arrows). This interstitial infiltration inflammatory cells can be seen in the early stages of infection prior to bronchopneumonia (<xref ref-type="bibr" rid="bib52">Lawlor et al., 2005</xref>; <xref ref-type="bibr" rid="bib103">Xiong et al., 2015</xref>). Furthermore, some infected <italic>Skap2-/</italic>- lungs (2/5 lungs) had lesions with cellular destruction and uncontrolled bacterial growth surrounded by sparse leukocyte infiltration (<xref ref-type="fig" rid="fig1">Figure 1K–L</xref>, blue arrows). To evaluate whether SKAP2-dependent control of <italic>K. pneumoniae</italic> colonization was required in a different mouse background, C57BL/6J, C57BL/6J <italic>Skap2-/-</italic>, or heterozygous littermates were inoculated retropharyngeally with <italic>K. pneumoniae</italic> (<xref ref-type="fig" rid="fig1">Figure 1M–N</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1K–N</xref>). At 24 hpi, C57BL/6 <italic>Skap2-/</italic>- mice had a significant increase in bacterial burden compared to C57BL/6 and heterozygous littermates (<xref ref-type="fig" rid="fig1">Figure 1M</xref>). In general, comparable numbers of neutrophils and inflammatory monocytes were detected in all three strains (<xref ref-type="fig" rid="fig1">Figure 1N</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1L–N</xref>) although the percent of neutrophils recovered in C57Bl/6 <italic>Skap2</italic>-/- mice was higher (<xref ref-type="fig" rid="fig1">Figure 1N</xref>) In summary, although leukocytes are present in the <italic>Skap2-/</italic>- lungs at comparable or slightly higher level to wild-type lungs, <italic>Skap2-/</italic>- mice were more susceptible to <italic>K. pneumoniae</italic> infection suggesting that their antimicrobial functions are compromised.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>Skap2-/</italic>- mice are more susceptible to <italic>K. pneumoniae</italic> intranasal infection.</title><p>(<bold>A–L</bold>) WT (BALB/c) and <italic>Skap2-/</italic>- mice were intranasally treated with PBS or infected with 5 × 10<sup>3</sup> cfu (red asterisk) of <italic>K. pneumoniae (Kp).</italic> At the indicated time points, (<bold>A</bold>) mice were weighed, lungs were harvested and single cell suspensions were prepared for (<bold>B</bold>) CFU and (<bold>C</bold>) analysis of neutrophils (CD11b<sup>+</sup>Ly6G<sup>hi</sup>). (<bold>D–L</bold>) At 24 hr post-infection or inoculation with PBS (mock), lungs were harvested and processed for HE-staining. (<bold>D</bold>) Lung tissue sections were scored for infiltrates of leukocytes or bacteria. Mock (<bold>E, I</bold>) or <italic>K. pneumoniae</italic>-infected (<bold>F–H, J–L</bold>) WT (<bold>E–H</bold>), and <italic>Skap2-/- (<bold>I–L</bold>)</italic>, lungs were imaged at 4X (<bold>E–G, I–K</bold>) or at 40X (<bold>H, L</bold>). Blue arrows indicate bacteria. Bacterial burden (<bold>M</bold>) and live neutrophils (CD11b<sup>+</sup>Ly6G<sup>hi</sup>) (<bold>N</bold>) from <italic>K. pneumoniae</italic>-infected C57BL/6, <italic>Skap2-/-</italic>, and <italic>Skap2+/-</italic> (Hets) littermates are shown. Data are compiled from 2 to 4 independent experiments with 2–4 mice/time point/genotype. (<bold>A</bold>) Mean ± SEM. (<bold>B–D, M–N</bold>) Each dot represents values from a mouse, and black bars represent geometric means (<bold>B, M</bold>) or means (<bold>C–D, N</bold>). Significance was assessed using (<bold>A</bold>) two-way ANOVA with Sidak’s post-test, or one-way ANOVA with Tukey’s post-test (<bold>M–N</bold>), or with Sidak’s post-test (<bold>B–C, D</bold>); log-transformed numbers were used for (<bold>B, M</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56656-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>WT and <italic>Skap2-/</italic>- mice have similar numbers of immune cells in lungs after <italic>K. pneumoniae</italic> intranasal infection.</title><p>(<bold>A–J</bold>) WT (open circles) and <italic>Skap2-/-</italic> (solid triangles) mice were intranasally inoculated with PBS or <italic>K. pneumoniae</italic> and assess for (<bold>A–D</bold>) neutrophils (CD11b<sup>+</sup>Ly6G<sup>hi</sup>), (<bold>E–F</bold>) alveolar macrophages (CD11b<sup>int</sup> CD11c<sup>hi</sup>), (<bold>F–H</bold>) dendritic cells (CD11b<sup>hi</sup> CD11c<sup>hi</sup>), and (<bold>I–J</bold>) resident monocytes (CD11b<sup>+</sup> Gr1<sup>lo</sup>). Data are compiled from 2 to 4 independent experiments (2–4 mice/time point/genotype). (<bold>K</bold>) Analysis of SKAP2 expression in C57Bl/6, <italic>Skap2</italic>-/- and <italic>Skap2</italic>+/- (Hets) by intercellular staining of SKAP2 followed by flow cytometry. (<bold>L–N</bold>) Neutrophils (CD11b<sup>+</sup>Ly6G<sup>hi</sup>) and iMOs (CD11b<sup>+</sup>Ly6C<sup>hi</sup> from <italic>K. pneumoniae</italic>-infected lungs of C57BL/6, <italic>Skap2-/-</italic>, and <italic>Skap2+/-</italic> (Hets) littermates by intracellular staining of SKAP2 followed by flow cytometry. (<bold>K–N</bold>) Data are compiled from 3 independent experiments. (<bold>A–J, L–N</bold>) Data are shown as percentage or cell number per 100 μl of lung homogenates as indicated on the axis. (<bold>A–N</bold>) Each dot represents a mouse; bars represent means. Significance was assessed using one-way ANOVA with Sidak’s post-test (<bold>A–J</bold>), two-tailed unpaired Student’s <italic>t</italic> test (<bold>K</bold>), or with Tukey’s post-test (<bold>L–N</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56656-fig1-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title><italic>Skap2</italic> expression in bone marrow-derived immune cells is required to control <italic>K. pneumoniae</italic> lung infection</title><p>To investigate whether <italic>Skap2</italic> expression in bone marrow-derived leukocytes was required for controlling the antibacterial response to <italic>K. pneumoniae</italic> infection, we generated bone marrow (BM) chimeric mice by transplanting WT or <italic>Skap2-/</italic>- BM cells into either WT or <italic>Skap2-/</italic>- mice (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Transplantation efficiency was confirmed by flow cytometry (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). WT recipient mice reconstituted with <italic>Skap2-/</italic>- BM had significantly more <italic>K. pneumoniae</italic> in contrast to WT mice transplanted with WT BM (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Conversely, <italic>Skap2-/</italic>- recipients with WT BM cells had significantly decreased <italic>K. pneumoniae</italic> in their lungs as compared to <italic>Skap2-/</italic>- hosts that received <italic>Skap2-/</italic>- BM cells (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The differences in bacterial burdens were not due to differences in numbers of neutrophils as equivalent numbers were recovered among all four groups of mice (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C–E</xref>). While fewer inflammatory monocytes (iMOs) were detected in <italic>Skap2-/</italic>- recipients regardless of BM cell donor, the difference did not correlate with bacterial load (<xref ref-type="fig" rid="fig2">Figure 2B,D</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F–H</xref>). Combined, these data indicate <italic>Skap2</italic> expression in BM-derived immune cells is required to contain <italic>K. pneumoniae</italic> growth during lung infection, and that <italic>Skap2</italic> expression in cells that are not derived from the marrow do not contribute to this phenotype.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Reconstitution of <italic>Skap2-/</italic>- mice with WT bone marrow hematopoietic stem cells confers protection against <italic>K. pneumoniae</italic>.</title><p>(<bold>A</bold>) Schematic used to generate bone marrow chimeras in (<bold>B–D, F</bold>). (<bold>B–F</bold>) Mice were infected with 5 × 10<sup>3</sup> cfu <italic>K. pneumoniae</italic> (red asterisk); 24 hpi mice were sacrificed and lungs harvested. (<bold>E–F</bold>) WT and <italic>Skap2-/</italic>- mice were injected intraperitoneally with 50 μg of α-Ly6G (1A8) or 20 μg of α-CCR2 (MC-21) to deplete neutrophils and iMOs, respectively, or PBS 16 hr prior to infection. Bacterial burden (<bold>B, E, F</bold>) and percent live neutrophils (CD11b<sup>+</sup> Ly6G<sup>hi</sup>) (<bold>C</bold>), or inflammatory monocytes (CD11b<sup>+</sup> Ly6C<sup>hi</sup>) (<bold>D</bold>) from <italic>K. pneumoniae</italic>-infected lungs. Data are compiled from 2 to 4 independent experiments using groups of 2–3 mice/genotype/experiment. Each dot represents a mouse, bars are geometric means (<bold>B, E–F</bold>) or means (<bold>C–D</bold>). Statistics were assessed using one-way ANOVA with (<bold>C–D</bold>) Sidak’s post-test, or (<bold>B, E–F</bold>) Tukey’s post-test. (<bold>D</bold>) Percent of iMOs were compiled, and comparison between WT and <italic>Skap2-/</italic>- irradiated recipient disregarding the donor BM were assessed by two-tailed unpaired Student’s <italic>t</italic> test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56656-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Transplantation efficiency of bone marrow reconstitution into WT and <italic>Skap2-/</italic>- recipients.</title><p>(<bold>A</bold>) Schematic for gating strategy of flow cytometry data in bone marrow chimeras. Blocks and arrows indicate the cell population used for next gating step. (<bold>B–H</bold>) Neutrophil (CD11b<sup>+</sup> Ly6G<sup>hi</sup>) (<bold>C–E</bold>), or inflammatory monocytes (CD11b<sup>+</sup> Ly6C<sup>hi</sup>) (<bold>F–H</bold>) from <italic>K. pneumoniae</italic>-infected lungs were unstained or intracellularly stained with SKAP2 antibody or isotype control. (<bold>B</bold>) SKAP2 expression in CD11b<sup>+</sup> cells shown as mean fluorescent intensity (MFI). Dotted line indicates average level from cells intracellularly stained with isotype control. Data are compiled from 2 to 4 independent experiments using 2–3 mice/genotype/experiment. Each dot represents a mouse, bar represents means. Statistical significance was assessed using one-way ANOVA with Sidak’s post-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56656-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Evaluation of immune cell populations in depletion studies in WT and <italic>Skap2-/</italic>- mice.</title><p>Analysis of inflammatory monocytes (CD11b<sup>+</sup> Gr1<sup>lo</sup> or CD11b<sup>+</sup> Ly6C<sup>hi</sup> Ly6G<sup>lo</sup>) and neutrophils (CD11b<sup>+</sup> Gr1<sup>hi</sup> or CD11b<sup>+</sup> Ly6C<sup>int</sup> Ly6G<sup>hi</sup>) from non-depleted (PBS), α-Ly6G (clone 1A8)-depleted, or MC-21-depleted (α-CCR2) <italic>K. pneumoniae</italic>-infected lungs. (<bold>A–B</bold>) Example of flow cytometry analysis for depletion experiments. (<bold>C–F</bold>) Quantification of neutrophils (CD11b<sup>+</sup> Gr1<sup>hi</sup>) (<bold>C–D</bold>), or inflammatory monocytes (CD11b<sup>+</sup> Ly6C<sup>hi</sup> Ly6G<sup>lo</sup>) (<bold>E–F</bold>) from α-Ly6G, α-CCR2, or PBS-treated, and <italic>K. pneumoniae</italic>-infected WT or <italic>Skap2-/</italic>- mice based on flow cytometry analysis. (<bold>G–J</bold>) Quantification of neutrophils (<bold>G–H</bold>), or inflammatory monocytes (<bold>I–J</bold>) from α-Ly6G, α-CCR2, or PBS-treated, <italic>K. pneumoniae</italic>-infected irradiated <italic>Skap2-/</italic>- mice based on flow cytometry analysis. Data are compiled from 3 to 4 independent experiments with 2–3 mice/genotype/experiment. Each dot represents a mouse, bars represent geometric means. (<bold>D, F, H, J</bold>) were log-transformed. Significance was assessed using one-way ANOVA with Tukey’s post-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56656-fig2-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title><italic>Skap2</italic> expression in neutrophils contributes to the protection against <italic>K. pneumoniae</italic> infection</title><p>The contribution of neutrophils and iMOs to host defense against <italic>K. pneumoniae</italic> infection is dependent on the bacterial strain used with <italic>K. pneumoniae</italic> ATCC 43816 being more susceptible to neutrophils (<xref ref-type="bibr" rid="bib103">Xiong et al., 2015</xref>; <xref ref-type="bibr" rid="bib87">Silver et al., 2019</xref>). To determine the role of neutrophils and iMOs in the increased susceptibility of <italic>Skap2-/</italic>- mice to <italic>K. pneumoniae</italic>, WT and <italic>Skap2-/</italic>- mice were treated with the α-Ly6G (clone 1A8) to deplete neutrophils, or the MC-21 antibody, which targets CCR2<sup>+</sup> cells to deplete iMOs (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Depletion efficiency was confirmed by flow cytometry (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A–F</xref>). While the <italic>K. pneumoniae</italic> burden in iMOs-depleted WT mice was similar to vehicle-treated mice, significantly more bacteria were recovered from the lungs of neutrophil-depleted WT mice (<xref ref-type="fig" rid="fig2">Figure 2E</xref>) confirming the importance of neutrophils in host defense (<xref ref-type="bibr" rid="bib105">Ye et al., 2001</xref>; <xref ref-type="bibr" rid="bib103">Xiong et al., 2015</xref>). The neutrophil-depleted WT mice had similarly high bacterial burdens as <italic>Skap2-/</italic>- mice (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), and the depletion of <italic>Skap2-/</italic>- mice of neutrophils or iMOs did not increase their bacterial burden suggesting that protection against <italic>K. pneumoniae</italic> infection is SKAP2-dependent (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><p>To assess the contribution of <italic>Skap2</italic> expression in BM-derived iMOs and neutrophils in limiting <italic>K. pneumoniae</italic> infection, iMOs and neutrophils were depleted from irradiated <italic>Skap2-/</italic>- mice that had been reconstituted with WT BM cells (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Depletion efficiency was confirmed by flow cytometry (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2G–J</xref>). As expected, reconstitution of <italic>Skap2-/</italic>- mice with WT BM resulted in a significant reduction in bacterial burden compared to <italic>Skap2-/</italic>- mice that received <italic>Skap2-/</italic>- BM cells (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). <italic>Skap2-/</italic>- mice that received WT BM and were then depleted of neutrophils with α-Ly6G showed an increase in bacterial load and that burden was similar to those in <italic>Skap2-/</italic>- mice that received <italic>Skap2-/</italic>- neutrophils (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). By contrast, α-CCR2-treated mice had a similar bacterial burden as PBS-treated mice (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Together, these data indicate that neutrophils cannot control <italic>K. pneumoniae</italic> 43816 infection in the absence of SKAP2 in the hematopoietic compartment. As <italic>Skap2-/</italic>- neutrophils are present in infected tissues (<xref ref-type="fig" rid="fig1">Figure 1D,J,N</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–D</xref>), the uncontrolled <italic>K. pneumoniae</italic> growth may occur because of defects in the antimicrobial functions of <italic>Skap2-/</italic>- neutrophils at the site of infection.</p></sec><sec id="s2-4"><title><italic>Skap2-/</italic>- differentiated in vitro (DIV) neutrophils phenocopied bone marrow-derived (BM) neutrophils morphologically and can used to investigate the role of SKAP2 in neutrophil functions</title><p>Neutrophils have multiple antimicrobial mechanisms to limit bacterial growth during infection (<xref ref-type="bibr" rid="bib32">Futosi et al., 2013</xref>; <xref ref-type="bibr" rid="bib67">Mócsai, 2013</xref>). To investigate which antimicrobial functions are controlled by SKAP2, the ER-Hoxb8 conditionally-immortalized stem cell system was adopted as a tool to produce a supply of neutrophils (<xref ref-type="bibr" rid="bib99">Wang et al., 2006</xref>; <xref ref-type="bibr" rid="bib18">Chu et al., 2019</xref>). Mouse BM-derived stem cells from WT and <italic>Skap2-/</italic>- mice were retrovirally transduced with Hoxb8 regulated by estrogen (ER-Hoxb8), and maintained in media containing estrogen (E2) and stem cell factor (SCF) to expand granulocyte-monocyte progenitors (GMP) in vitro (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–I</xref> and see Materials and Methods). Removal of E2 inactivates Hoxb8 expression and the addition of interleukin-3 and granulocyte colony-stimulating factor led to terminal neutrophil differentiation (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–I</xref>). Neutrophil maturation from WT and <italic>Skap2-/</italic>- ER-HoxB8-immortalized GMP cells (Hoxb8 GMP) was evaluated by nuclear morphology (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>) and cell surface expression of cKit, CD11b and Ly6G (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C–D,G–I</xref>). Hoxb8 GMP cells were mononuclear and cKit<bold><sup>+</sup></bold> CD11b<bold><sup>-</sup></bold> Ly6G<bold><sup>-</sup></bold> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C–D,G–I</xref>). Cells from both mouse lines differentiated by day 4 and were comparably viable (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E–F</xref>). Fully differentiated cells are referred to as <underline>d</underline>ifferentiated <underline>i</underline>n <underline>v</underline>itro (DIV) neutrophils. Like BM-derived neutrophils, DIV neutrophils expressed polymorphonuclear morphology and are cKit<bold><sup>-</sup></bold> CD11b<bold><sup>+</sup></bold> Ly6G<bold><sup>+</sup></bold> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B–D,G–I</xref>).</p><p>To confirm the functionality of DIV neutrophils in comparison to BM neutrophils, their ability to generate reactive oxygen species (ROS) following integrin and Fcγ receptor stimulation was assessed (<xref ref-type="bibr" rid="bib18">Chu et al., 2019</xref>). When plated onto surfaces coated with poly-RGD, an engineered polypeptide containing multiple copies of the integrin binding motif, WT BM and DIV neutrophils released superoxide, while <italic>Skap2-/</italic>- BM and DIV neutrophils did not (<xref ref-type="fig" rid="fig3">Figure 3A–C</xref>). This is consistent with previously published data in C57BL/6J and <italic>Skap2-/</italic>- BM neutrophils (<xref ref-type="bibr" rid="bib10">Boras et al., 2017</xref>). The loss in integrin-mediated ROS production was not due to defects in the NADPH oxidase itself, as <italic>Skap2-/</italic>- BM and DIV neutrophils robustly released ROS when stimulated with phorbol myristate acetate (PMA), which bypasses receptor-mediated signaling pathways and activates NADPH oxidase via protein kinase C (PKC) (<xref ref-type="bibr" rid="bib23">Dang et al., 2001</xref>; <xref ref-type="fig" rid="fig3">Figure 3C</xref>). By contrast, after stimulation of Fcγ receptors by IgG immune complexes (IC), WT and <italic>Skap2-/</italic>- BM and DIV neutrophils robustly produced ROS (<xref ref-type="fig" rid="fig3">Figure 3D–F</xref>). <italic>Skap2-/</italic>- BM and DIV neutrophils consistently released 60–80% as much ROS as compared to levels seen in comparable WT neutrophils. This indicates IC-stimulated ROS is partially dependent on SKAP2. Differences in ROS production were not due to differences in surface marker expression levels as WT and <italic>Skap2-/</italic>- DIV neutrophils expressed similar levels of integrin and Fcγ receptors as measured by CD11b and CD16 expression, respectively, by flow cytometry (<xref ref-type="fig" rid="fig3">Figure 3G–J</xref>). Combined, these results indicate WT and <italic>Skap2-/</italic>- DIVs phenocopy primary BM neutrophils both morphologically and functionally and are a useful tool to investigate how SKAP2 modulates <italic>K. pneumoniae</italic>-induced neutrophil responses. Furthermore, these data suggest that a functional NADPH complex can assemble in <italic>Skap2-/</italic>- neutrophils and that SKAP2 is required for receptor-activated signaling pathways downstream of integrin receptors, but not Fcγ receptors.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>BM and DIV neutrophils require SKAP2 for integrin-activated ROS production, but not for FcγR.</title><p>(<bold>A–F</bold>) Extracellular respiratory burst of BM and DIV neutrophils. WT or <italic>Skap2-/</italic>- neutrophils were plated on a poly-RGD-coated surface (<bold>A–C</bold>), or IgG immune complex (IC)-coated surface (<bold>D–F</bold>), and superoxide production was measured by cytochrome C reduction. Unstimulated (unstim) cells were plated onto 10% FBS/PBS or stimulated with 100 nM PMA. (<bold>C, F</bold>) Total concentration of superoxide produced after 60 min. (<bold>G–J</bold>) Expression of surface receptors on DIV neutrophils of CD11b (<bold>G–H</bold>) or activating CD16 Fcγ receptor (<bold>I–J</bold>). (<bold>G–J</bold>); Blue shaded areas and bars represent WT, and red, <italic>Skap2-/-</italic>. (<bold>A–B, D–E</bold>) represent the mean ± SD of one experiment in technical triplicate assessed using two-way ANOVA with Tukey’s post-test. (<bold>C, F, H, J</bold>) represent the mean ± SEM of at least three independent experiments performed in at least technical duplicate (<bold>C, F</bold>) and were assessed using two-way ANOVA with Tukey’s post-test (<bold>C, F</bold>), or two-tailed unpaired Student’s <italic>t</italic> test (<bold>H, J</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56656-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Hoxb8-transformed GMP differentiate into neutrophils with similar morphology and surface markers to that of BM-derived neutrophils.</title><p>(<bold>A</bold>) Schematic of MSCV-Hoxb8 transduction system to generate immortalized stem cell progenitors. The estrogen-binding domain (ERBD) of the estrogen receptor fused to Hoxb8 with an N-terminal Flag epitope tag allows conditional expression of Hoxb8 in the presence of estrogen. After 4 days of differentiation, cells are referred to as DIV neutrophils. (<bold>B</bold>) Nuclear morphology of BM-derived neutrophils isolated from WT or <italic>Skap2-/</italic>- mice, HoxB8 GMP, and DIV neutrophils with DAPI. Red arrows indicate polymorphonuclear nuclei. (<bold>C</bold>) Analysis of c-Kit and CD11b expression. (<bold>D</bold>) Analysis for Ly6G expression on live CD11b+ cells. (<bold>E–F</bold>) Viability of WT and <italic>Skap2-/</italic>- DIV neutrophils was assessed using (<bold>E</bold>) trypan blue exclusion test from neutrophils differentiated from Hoxb8 immortalized GMP from 2 different WT and <italic>Skap2-/</italic>- mice prior to functional studies, or (<bold>F</bold>) DIV neutrophils were plated into 10%FBS/PBS-coated wells, loaded with CellTiter Glo reagent, and chemiluminescence was detected for 30 min by plate reader. The quantification of ATP is shown as relative light units (RLU) from one experiment done in technical triplicate. (<bold>G–I</bold>) Quantification of (<bold>G</bold>) cKit+, (<bold>H</bold>) CD11b+, or (<bold>I</bold>) CD11b+ Ly6G+ cells from Hoxb8 GMP, day 4 DIV neutrophils (DIV), and BM neutrophils (BM). Results are compiled from 1 to 4 independent experiments with each dot representing one experiment and are shown as mean ± SEM. Significance was determined by one-way ANOVA with Sidak’s post-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56656-fig3-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Protection against <italic>K. pneumoniae</italic> is not dependent on degranulation or phagocytosis</title><p>Multiple neutrophil antimicrobial mechanisms, including degranulation, phagocytosis, and NETs, have been implicated in host defense against <italic>K. pneumoniae</italic> infection (<xref ref-type="bibr" rid="bib17">Chen et al., 2016</xref>; <xref ref-type="bibr" rid="bib45">Ivin et al., 2017</xref>; <xref ref-type="bibr" rid="bib74">Papayannopoulos et al., 2010</xref>; <xref ref-type="bibr" rid="bib8">Bengoechea and Sa Pessoa, 2019</xref>; <xref ref-type="bibr" rid="bib73">Paczosa and Mecsas, 2016</xref>; <xref ref-type="bibr" rid="bib42">Hirche et al., 2005</xref>; <xref ref-type="bibr" rid="bib108">Zhao et al., 2015</xref>; <xref ref-type="bibr" rid="bib48">Kobayashi et al., 2016</xref>). To examine whether <italic>Skap2-/</italic>- neutrophils degranulated as efficiently as WT neutrophils during <italic>K. pneumoniae</italic> infection, we measured levels of released MMP-9 and neutrophil elastase (ELA2), proteins found in tertiary and primary granules, respectively (<xref ref-type="bibr" rid="bib74">Papayannopoulos et al., 2010</xref>; <xref ref-type="bibr" rid="bib85">Sheshachalam et al., 2014</xref>). Supernatants from WT and <italic>Skap2-/- K. pneumoniae</italic>-infected lungs had equivalent levels of MMP-9 and ELA2 in <italic>Skap2-/</italic>- at 16 and 24 hpi as detected by ELISA (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>). This suggests that the increased in susceptibility of <italic>Skap2-/</italic>- mice was not due to defects in degranulation.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>SKAP2 is not required for <italic>K. pneumoniae</italic>-stimulated degranulation nor phagocytosis.</title><p>(<bold>A–B</bold>) Levels of (<bold>A</bold>) total MMP-9, and (<bold>B</bold>) neutrophil elastase (ELA2) from cell-free supernatant from <italic>K. pneumoniae-</italic>infected WT and <italic>Skap2-/</italic>- lung homogenates were analyzed by ELISA. Data are compiled from 2 to 4 independent experiments with 2–3 mice/genotype/experiment. Each dot represents a mouse and bars represent geometric means. (<bold>C</bold>) WT and <italic>Skap2-/</italic>- DIV neutrophils were incubated with encapsulated (<italic>Kp</italic>), unencapsulated (<italic>ΔcpsB Kp</italic>) <italic>K. pneumoniae,</italic> or <italic>Yptb ΔyscNU</italic>. Percent phagocytosis was calculated as CFU<sub>bacteria with neutrophils and gentamicin</sub>/CFU<sub>bacteria without gentamicin treatment</sub>. (<bold>A–C</bold>) Data are compiled from at least 3 independent experiments performed in technical triplicate. Statistics represent mean ± SEM and were assessed using one-way ANOVA with Sidak’s post-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56656-fig4-v2.tif"/></fig><p>To determine the role of SKAP2 in phagocytosis of <italic>K. pneumoniae</italic>, phagocytosis was initially measured using microscopy. However, microscopic examination of WT DIV neutrophils infected with GFP-labeled <italic>K. pneumoniae</italic> and counterstained with Alexa594-conjugated polyvalent α-<italic>K. pneumoniae</italic> for extracellular bacteria did not reveal any internalized bacteria indicating that phagocytosis levels were less than 1% (unpublished data). Using a more sensitive gentamicin protection assay (<xref ref-type="bibr" rid="bib98">Walker et al., 2019</xref>), <italic>K. pneumoniae</italic> 43816 was recovered on average at less than 0.01% in WT and <italic>Skap2-/</italic>- DIV neutrophils, while a non-encapsulated (<italic>ΔcpsB</italic>) <italic>K. pneumoniae</italic> strain was recovered at approximately 0.05% (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). This low level was not due to a defect in phagocytosis of DIV neutrophils as WT and <italic>Skap2-/</italic>- DIV neutrophils were able to phagocytose <italic>Yersinia pseudotuberculosis</italic> YPIII <italic>ΔyscNU</italic> strain, a strain that is susceptible to phagocytosis (<xref ref-type="bibr" rid="bib5">Balada-Llasat and Mecsas, 2006</xref>). WT and <italic>Skap2-/</italic>- DIV neutrophils phagocytosed 20% and 10% of <italic>ΔyscNU,</italic> respectively (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), suggesting that phagocytosis of this <italic>Y. pseudotuberculosis</italic> strain is partially dependent on SKAP2. Although we observed low level of phagocytosis of <italic>K. pneumoniae</italic> 43816, the SKAP2-mediated defect in phagocytosis might be more prominent when challenged with other <italic>K. pneumoniae</italic> isolates. Combined, these results indicate that the <italic>K. pneumoniae</italic> 43816 strain is resistant to neutrophil phagocytosis regardless of SKAP2 expression, but can elicit SKAP2-independent degranulation during infection.</p></sec><sec id="s2-6"><title>SKAP2 is required for <italic>K. pneumoniae</italic>-induced neutrophil ROS production</title><p>ROS is an important mechanism for protection against <italic>K. pneumoniae</italic> as mice that lack the essential gp91<sup>phox</sup> component of NADPH oxidase, <italic>Cybb-/-</italic>, were significantly more susceptible to <italic>K. pneumoniae</italic> infection and had a significant increase in bacterial burden in their lungs (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>; <xref ref-type="bibr" rid="bib72">Paczosa et al., 2020</xref>). To test whether SKAP2 deficiency resulted in a defect in neutrophil ROS production after <italic>K. pneumoniae</italic> infection, an isoluminol-amplified chemiluminiscence assay was used. In contrast to WT BM and DIV neutrophils, neither <italic>Skap2-/</italic>- BM nor DIV neutrophils produced ROS following exposure to <italic>K. pneumoniae</italic> (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B-C</xref>). The loss of <italic>K. pneumoniae</italic>-stimulated ROS production was not due to a defect in bacterial-binding as WT and <italic>Skap2-/</italic>- DIV neutrophils bound GFP-labeled <italic>K. pneumoniae</italic> equivalently when assessed by flow cytometry following both 15- and 30 min incubations (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Without treating the cells with actin inhibitor, such as cytochalasin B, bound and phagocytosed bacteria could contribute to the levels of GFP<sup>+</sup> cells. However, the less than 1% of internalization of <italic>K. pneumoniae</italic> observed in the gentamicin protection assay (<xref ref-type="fig" rid="fig4">Figure 4C</xref>) suggests that the majority of the bacteria are extracellular, and that GFP<sup>+</sup> cells are more likely reflective of binding. Finally, SKAP2 was important for ROS production after infection with another gram-negative bacterial strain, a type 3 deficient <italic>Y. pseudotuberculosis</italic> strain, Δ<italic>yscF</italic> (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). In summary, <italic>Skap2-/</italic>- neutrophils are defective in triggering the signaling cascade(s) required for ROS after <italic>K. pneumoniae</italic> binding to surface receptors.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>K. pneumoniae</italic>-stimulated ROS production requires SKAP2-dependent activation of tyrosine kinases.</title><p>(<bold>A–C</bold>) Respiratory burst of WT and <italic>Skap2-/</italic>- DIV neutrophils infected with <italic>Kp</italic> using isoluminol-chemiluminsence. Unstimulated (unstim), <italic>Kp</italic>-infected, and 100 nM PMA-treated cells were seeded on FBS-coated wells. (<bold>A</bold>) Representative experiment performed in triplicate of ROS (RLU) production following <italic>K. pneumoniae</italic> stimulation. (<bold>B</bold>) Total ROS (total RLU) produced after 30 min of stimulation was calculated as the total area under the curve shown in (<bold>A</bold>) of 4 independent experiments performed in technical triplicate. (<bold>C</bold>) WT and <italic>Skap2-/</italic>- neutrophils incubated with GFP-expressing <italic>K. pneumoniae</italic> (<italic>Kp</italic>-GFP) at MOI 40 for 15 or 30 min, stained with DAPI, and analyzed by flow cytometry for GFP-associated neutrophils. (<bold>D</bold>) Schematic of potential <italic>K. pneumoniae-</italic>activated signaling pathways tested by inhibitors. (<bold>E</bold>) Respiratory burst of WT DIV neutrophils untreated or treated with inhibitors using isoluminol-chemiluminescence assay. DIV neutrophils were pre-treated with DMSO, PP2 (iSFKs), R406 (iSyk), Ibrutinib (iBtk), Go 6083 (iPKC), U73122 (iPLCγ), or U73134 (nPLCγ/non-inhibitory analog of PLCγ inhibitor) for 10 min at 37°C and then infected with MOI 2.5 of <italic>K. pneumoniae</italic> or treated with 100 nM PMA and measured for 30 min. Total RLU was calculated as area under the curve. Data are a representative figure from 3 independent experiments showing mean ± SD performed in technical triplicate. Significance was assessed using one-way ANOVA with Sidak’s post-test. (<bold>F–L</bold>) WT and <italic>Skap2-/</italic>- neutrophils were infected with <italic>Kp</italic> for 10 or 15 min or stimulated with IC for 10 min at 37°C. Lysates were analyzed by western blot for pSFKs (Y416), pSyk (Y352), pPyk2 (Y402), and RhoGDI. Blots were then stripped and re-probed for total Syk or Pyk2. Data are compiled from 3 independent experiments. (<bold>B–C</bold>) Data are compiled from 2 to 4 independent experiments performed in technical triplicate. Statistics represent mean ± SEM. (<bold>F, H, K</bold>) Representative blot shown. (<bold>G, I, L</bold>) Solid symbols indicate values of blot shown. Bars indicate mean. Significance was assessed using one-way ANOVA (<bold>B</bold>) with Sidak’s post-test between WT and <italic>Skap-2-/-</italic>, or (<bold>G, I, L</bold>) between time points within each genotype, or two-way ANOVA with Sidak’s post-test between WT and <italic>Skap2-/</italic>- within the same point.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56656-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>ROS restricts <italic>K. pneumoniae</italic> infection in lungs and is induced by <italic>K. pneumoniae</italic> after infection of BM neutrophils.</title><p>(<bold>A</bold>) Bacterial burden of wild-type C57BL/6 and <italic>Cybb-/-</italic> mice retropharyngeally infected with 5 × 10<sup>3</sup> cfu <italic>K. pneumoniae</italic> for 24 hr. Data are compiled from 2 independent experiments with 3–4 mice/genotype/experiment. Each dot represents a mouse and bars represent geometric means. Significance was assessed using two-tailed unpaired Student’s <italic>t</italic> test. (<bold>B–C</bold>) Respiratory burst of WT and <italic>Skap2-/</italic>- BM neutrophils with <italic>K. pneumoniae</italic> at the indicated MOI using an isoluminol-chemiluminesence assay. (<bold>B</bold>) Representative experiment of ROS (RLU) production following stimulation with <italic>K. pneumoniae</italic>, or PMA done in technical duplicate. (<bold>C</bold>) Total ROS (total RLU) produced after 30 min of stimulation from one experiment shown as mean ± SD. (<bold>D</bold>) Respiratory burst of WT and <italic>Skap2-/</italic>- BM neutrophils with <italic>Y. pseudotuberculosis ΔyscF</italic> at MOI 10 using an isoluminol-chemiluminesence assay.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56656-fig5-figsupp1-v2.tif"/></fig></fig-group><p>To investigate how SKAP2 mediates <italic>K. pneumoniae</italic>-induced ROS production, we first evaluated the requirement for several well-established proteins that are critical for receptor-mediated ROS production after <italic>K. pneumoniae</italic> infection. Src family kinases (SFKs), Spleen Associated Tyrosine Kinase (Syk), Bruton’s tyrosine kinase (Btk), Phospholipase Cγ2 (PLCγ2), and PKC play critical roles in receptor-mediated ROS production (<xref ref-type="bibr" rid="bib54">Löfgren et al., 1999</xref>; <xref ref-type="bibr" rid="bib12">Braselmann et al., 2006</xref>; <xref ref-type="bibr" rid="bib96">Volmering et al., 2016</xref>; <xref ref-type="bibr" rid="bib23">Dang et al., 2001</xref>; <xref ref-type="bibr" rid="bib79">Raad et al., 2009</xref>; <xref ref-type="bibr" rid="bib50">Kovács et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Fumagalli et al., 2007</xref>; <xref ref-type="bibr" rid="bib36">Graham et al., 2007</xref>; <xref ref-type="bibr" rid="bib70">Nguyen et al., 2017</xref>). To determine whether these proteins are required for <italic>K. pneumoniae</italic>-stimulated ROS production, WT DIV neutrophils were pretreated with PP2, R406, Ibrutinib, U-73122, and Go6983, which are small molecules that inhibit the functions of SFKs, Syk, Btk, PLCγ2, and PKC (both novel and conventional isoforms), respectively (<xref ref-type="fig" rid="fig5">Figure 5D</xref>; <xref ref-type="bibr" rid="bib76">Peterman et al., 2004</xref>; <xref ref-type="bibr" rid="bib12">Braselmann et al., 2006</xref>; <xref ref-type="bibr" rid="bib81">Rolán et al., 2013</xref>; <xref ref-type="bibr" rid="bib77">Prezzo et al., 2019</xref>; <xref ref-type="bibr" rid="bib31">Fumagalli et al., 2007</xref>). The DIV neutrophils were then infected with <italic>K. pneumoniae</italic>. Pretreatment with PP2, R406, Ibrutinib, U-73122, and Go6983 abolished ROS production after <italic>K. pneumoniae</italic> infection compared to vehicle-pretreated neutrophils (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). As expected, only pretreatment with Go6983 blocked ROS after PMA exposure. U73433, an U73122 analog that does not target PLCγ, did not block <italic>K. pneumoniae</italic>- and PMA-induced ROS (<xref ref-type="fig" rid="fig5">Figure 5E</xref>; <xref ref-type="bibr" rid="bib81">Rolán et al., 2013</xref>). This suggests SFKs, Syk, Btk, PLCγ2, and PKC are each necessary for <italic>K. pneumoniae-</italic>activated ROS production.</p><p>Next, we assessed whether SKAP2 mediates <italic>K. pneumoniae</italic>-induced ROS production by influencing tyrosine phosphorylated-dependent functions of SFKs and Syk. To determine whether SFKs and Syk are phosphorylated in response to <italic>K. pneumoniae</italic> infection, western blots of lysates from <italic>K. pneumoniae-</italic>infected WT DIV neutrophils were probed with phospho-specific antibodies. Infection with <italic>K. pneumoniae</italic> induced phosphorylation of SFKs (pSFK) and Syk (pSFK) to levels 2–5-fold higher than in unstimulated neutrophils (<xref ref-type="fig" rid="fig5">Figure 5F–I</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). These results support findings with inhibitors showing that SFKs and Syk functions are required for <italic>K. pneumoniae</italic>-activated ROS (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). In addition, proline-rich tyrosine kinase 2 (Pyk2), which is a tyrosine kinase that functions downstream of SFKs and Syk to mediate ROS production (<xref ref-type="bibr" rid="bib47">Kamen et al., 2011</xref>; <xref ref-type="bibr" rid="bib109">Zhao and Bokoch, 2005</xref>), was phosphorylated in response to <italic>K. pneumoniae</italic> stimulation (<xref ref-type="fig" rid="fig5">Figure 5K–L</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Thus, signaling circuit(s) containing SFKs, Syk, and Pyk2 were activated in neutrophils following receptor binding of <italic>K. pneumoniae</italic>. To determine if SKAP2 is required for phosphorylation of these tyrosine kinases, the levels of pSFKs, pSyk, and pPyk2 were assessed in <italic>Skap2-/</italic>- DIV neutrophils following <italic>K. pneumoniae</italic> exposure. While SFKs, Syk, and Pyk2 phosphorylation were all slightly induced in <italic>Skap2-/</italic>- neutrophils, the level of induction was often significantly reduced as compared to WT neutrophils (<xref ref-type="fig" rid="fig5">Figure 5F–L</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). To determine if the reduction in phosphorylation was due to decreased cell viability, <italic>Skap2-/</italic>- DIV neutrophils were also stimulated with IC as a control. Stimulation of FcγRs resulted in the phosphorylation for SFKs, Syk, and Pyk2 to similar levels in both WT and <italic>Skap2-/</italic>- DIV neutrophils (<xref ref-type="fig" rid="fig5">Figure 5F,H,K</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Collectively, these results show that SFKs, Syk, and Pyk2 are required for <italic>K. pneumoniae</italic>-stimulated ROS production, and that the loss of SKAP2 prevents full phosphorylation of SFKs, Syk, and Pyk2 after <italic>K. pneumoniae</italic> stimulation such that neutrophils are unable to generate ROS production.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our experiments reveal that SKAP2 plays a key role in host defense in the hematopoietic compartment against <italic>K. pneumoniae</italic> 43816 in pulmonary infections in a murine lung model of infection. SKAP2 was indispensable for <italic>K. pneumoniae</italic>-stimulated neutrophil ROS production, but not degranulation or phagocytosis, suggesting that the increased bacterial burden in the <italic>Skap2-/</italic>- mice is affected by the loss of ROS. Sensitivity of <italic>K. pneumoniae</italic> to ROS is strongly supported by the increased bacterial burden in <italic>Cybb-/-</italic> mice during lung infection, and observations in CGD patients (<xref ref-type="bibr" rid="bib102">Wolach et al., 2017</xref>; <xref ref-type="bibr" rid="bib72">Paczosa et al., 2020</xref>). In murine neutrophils, SKAP2 was required for full phosphorylation of SFKs, Syk, and Pyk2, demonstrating a critical role in <italic>K. pneumoniae</italic>-induced signaling pathways that are required for ROS production. Consistent with previous findings (<xref ref-type="bibr" rid="bib80">Regueiro et al., 2006</xref>; <xref ref-type="bibr" rid="bib58">March et al., 2013</xref>), <italic>K. pneumoniae</italic> 43816 was resistant to internalization indicating that phagocytosis is most likely not the primary protective mechanism provided by neutrophils to this strain. Prior studies, including one using <italic>K. pneumoniae</italic> 43816, have shown that degranulation of myeloperoxidase, ELA2, and cathepsin G are important for reducing bacterial burden of <italic>K. pneumoniae</italic> in mice (<xref ref-type="bibr" rid="bib42">Hirche et al., 2005</xref>; <xref ref-type="bibr" rid="bib108">Zhao et al., 2015</xref>). However, we found that despite equivalent levels of ELA2, degranulation in <italic>Skap2-/</italic>- mice was not sufficient to control <italic>K. pneumoniae</italic> burden in the absence of ROS, indicating that neutrophil ROS and degranulation may cooperate in containing <italic>K. pneumoniae</italic> infection. Since degranulation occurred normally in <italic>Skap2-/</italic>- lungs, the pathways of ROS production are distinct from signaling pathways regulating degranulation in murine neutrophils after <italic>K. pneumoniae</italic> infection. Neutrophils and ROS contribute to the defense against other pathogens such as <italic>Y. pseudotuberculosis</italic>, <italic>Staphylococcus aureus</italic>, <italic>Candida albicans</italic>, among others (<xref ref-type="bibr" rid="bib37">Green et al., 2016</xref>; <xref ref-type="bibr" rid="bib67">Mócsai, 2013</xref>; <xref ref-type="bibr" rid="bib70">Nguyen et al., 2017</xref>). The immunological mechanisms of SKAP2-mediated neutrophil responses to other pathogens are under investigation.</p><p>We propose the following model for SKAP2-dependent neutrophilic response to <italic>K. pneumoniae</italic> in mice based our findings and work of others (<xref ref-type="fig" rid="fig6">Figure 6</xref>; <xref ref-type="bibr" rid="bib2">Alenghat et al., 2012</xref>; <xref ref-type="bibr" rid="bib89">Swanson et al., 2008</xref>; <xref ref-type="bibr" rid="bib93">Togni et al., 2005</xref>; <xref ref-type="bibr" rid="bib92">Timms et al., 1999</xref>). Following <italic>K. pneumoniae</italic> infection, activation of receptors, like GPCRs recognizing N-formylated bacterial proteins or mincle recognizing bacterial lectins, leads to the activation of phosphoinositide 3 kinase (PI3K) and the generation of phosphatidylinositol [3,4,5]-triphosphate (PIP<sub>3</sub>), resulting in PIP<sub>3</sub>-mediated SKAP2 activation and membrane localization (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>; <xref ref-type="bibr" rid="bib32">Futosi et al., 2013</xref>; <xref ref-type="bibr" rid="bib89">Swanson et al., 2008</xref>; <xref ref-type="bibr" rid="bib83">Sharma et al., 2014</xref>; <xref ref-type="bibr" rid="bib2">Alenghat et al., 2012</xref>). The activated (open) phosphorylated SKAP2 complex can then bind to and enhance phosphorylation of SFKs shifting their active/inactive equilibrium to more active forms and leading to Syk activation (<xref ref-type="fig" rid="fig6">Figure 6B</xref>; <xref ref-type="bibr" rid="bib59">Marie-Cardine et al., 1998</xref>; <xref ref-type="bibr" rid="bib14">Bureau et al., 2018</xref>; <xref ref-type="bibr" rid="bib49">Kouroku et al., 1998</xref>; <xref ref-type="bibr" rid="bib56">Lowell, 2011</xref>). This is supported by previous biochemical and pull-down studies showing that SKAP2 can directly interact with SFKs (<xref ref-type="bibr" rid="bib14">Bureau et al., 2018</xref>; <xref ref-type="bibr" rid="bib53">Liu et al., 1998</xref>; <xref ref-type="bibr" rid="bib100">Wang and Rudd, 2008</xref>). SFKs and Syk may directly associate with and activate Pyk2, as observed in response to GPCRs, integrin, TNFα, and/or <italic>Salmonella</italic> stimulation (<xref ref-type="bibr" rid="bib25">Dikic et al., 1996</xref>; <xref ref-type="bibr" rid="bib27">Evangelista et al., 2007</xref>; <xref ref-type="bibr" rid="bib40">Han et al., 2003</xref>; <xref ref-type="bibr" rid="bib65">Mócsai et al., 2002</xref>). Furthermore, SKAP2 may interact with Pyk2 signaling complex directly or indirectly through their association with Sirpα (<xref ref-type="bibr" rid="bib78">Raab et al., 2017</xref>; <xref ref-type="bibr" rid="bib2">Alenghat et al., 2012</xref>). Any of these mechanisms would promote stabilization and propagation of SFKs/Syk/Pyk2 phosphorylation in activated murine neutrophil leading to ROS.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Proposed model of <italic>K. pneumoniae</italic>-stimulated signaling pathway.</title><p>(<bold>A</bold>) At resting state, the homodimer SKAP2 is in an autoinhibited conformation because of binding of the DM domains; SKAP2 is constitutively associated with PRAM-1 but is apart from other components of the signaling pathways. (<bold>B</bold>) Activation of neutrophils through the binding of <italic>K. pneumoniae</italic> leads to production of PIP3 which binds SKAP2, relieving the autoinhibited conformation and revealing sites for docking and centralization of other signaling molecules. SKAP2 docking sites may centralize and retain signaling molecules thereby increasing their local concentration to facilitate increased phosphorylation and amplification of their signals. Alternatively, SKAP2 may directly activate one or more tyrosine kinases, including SFKs, Syk, and Pyk2, leading to ROS production.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-56656-fig6-v2.tif"/></fig><p>While SFKs, Syk, and Pyk2 have been shown to be important for degranulation in murine and human neutrophils (<xref ref-type="bibr" rid="bib95">Van Ziffle and Lowell, 2009</xref>; <xref ref-type="bibr" rid="bib47">Kamen et al., 2011</xref>; <xref ref-type="bibr" rid="bib64">Mócsai et al., 1999</xref>; <xref ref-type="bibr" rid="bib40">Han et al., 2003</xref>), we observed degranulation in murine lungs and low levels of phosphorylation after <italic>K. pneumoniae</italic> infection in murine neutrophils in vitro. These low levels may be sufficient to induced degranulation through a SKAP2-independent signaling pathway. Alternatively, specific phosphorylation sites of SFKs or Syk not tested here may still occurred in the absence of SKAP2 and be sufficient to induce degranulation (<xref ref-type="bibr" rid="bib16">Carsetti et al., 2009</xref>; <xref ref-type="bibr" rid="bib94">Tsang et al., 2008</xref>; <xref ref-type="bibr" rid="bib69">Moroco et al., 2014</xref>; <xref ref-type="bibr" rid="bib66">Mócsai et al., 2010</xref>). In addition, different domains of Pyk2 regulate ROS and degranulation (<xref ref-type="bibr" rid="bib40">Han et al., 2003</xref>). Specifically, the inhibition of the carboxy-terminus of Pyk2 in human neutrophils leads to a reduction in ROS production in response to TNF, <italic>Salmonella</italic>, and <italic>Listeria</italic>, but did not impair neutrophil degranulation and bacterial killing (<xref ref-type="bibr" rid="bib40">Han et al., 2003</xref>). SKAP2 may impact the carboxy-terminus of Pyk2 in murine neutrophils, but not activation of other domains.</p><p><italic>Skap2-/</italic>- mice have normal levels of circulating neutrophils and <italic>Skap2-/- </italic>neutrophils were present in <italic>K. pneumoniae</italic>-infected lungs at a similar, and sometimes higher, levels as WT neutrophils (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>) and (<xref ref-type="bibr" rid="bib93">Togni et al., 2005</xref>). However, prior studies revealed that <italic>Skap2-/</italic>- myeloid cells, including neutrophils, have impaired recruitment and migration into tissues during sterile inflammation (<xref ref-type="bibr" rid="bib90">Tanaka et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Boras et al., 2017</xref>). This suggests that migration to sterile, but not infectious sites, may require SKAP2, which is consistent with findings with Syk. Syk is required for neutrophil migration in an inflammatory model but not during bacterial infection (<xref ref-type="bibr" rid="bib106">Zarbock et al., 2007</xref>; <xref ref-type="bibr" rid="bib30">Frommhold et al., 2007</xref>; <xref ref-type="bibr" rid="bib95">Van Ziffle and Lowell, 2009</xref>; <xref ref-type="bibr" rid="bib82">Schymeinsky et al., 2006</xref>). Alternatively, it is possible that <italic>Skap2-/</italic>- neutrophils may have a reduced migration level in <italic>K. pneumoniae</italic>-infected lungs but this is balanced by significantly higher rate of neutrophil survival and these two factors result in a net neutrophil level that is equivalent to or higher than that observed in WT mice. This result could arise because ROS production can increase myeloid cell death (<xref ref-type="bibr" rid="bib20">Coxon et al., 1996</xref>; <xref ref-type="bibr" rid="bib35">Geering and Simon, 2011</xref>; <xref ref-type="bibr" rid="bib34">Geering et al., 2011</xref>), and thus, defects in ROS production by <italic>Skap2-/</italic>- neutrophils could contribute to higher survival and accumulation in infected murine lungs. These possibilities are important to address with additional experiments, such as pulse-labelling newly differentiated neutrophils to track rates of migration during infection in vivo.</p><p>Murine models of infection have been helpful in illuminating <italic>K. pneumoniae</italic> infection biology, however, there exist significant differences between mice and humans in the immune response to infection, including disparities in structural anatomy, circulating neutrophil counts, surface receptors, and signaling cascades, among others (<xref ref-type="bibr" rid="bib63">Mizgerd and Skerrett, 2008</xref>; <xref ref-type="bibr" rid="bib61">Mestas and Hughes, 2004</xref>; <xref ref-type="bibr" rid="bib19">Condliffe et al., 2005</xref>; <xref ref-type="bibr" rid="bib39">Hajjar et al., 2010</xref>; <xref ref-type="bibr" rid="bib88">Sun et al., 2016</xref>; <xref ref-type="bibr" rid="bib4">Bagaitkar et al., 2012</xref>; <xref ref-type="bibr" rid="bib8">Bengoechea and Sa Pessoa, 2019</xref>). Thus, to date it is unknown if SKAP2 plays a role in mediating the human neutrophil response to <italic>K. pneumoniae</italic> infection. <italic>Skap2</italic> has 9 transcripts and at least 50 exonic variants that have been reported in the human population, however, their functional consequences, if any, remains unclear (<xref ref-type="bibr" rid="bib21">Cunningham et al., 2019</xref>). It would be interesting to explore if the SKAP2-mediated <italic>K. pneumoniae</italic>-stimulated responses occur in human neutrophils, and whether neutrophils (or other cell types) from individuals carrying specific <italic>Skap2</italic> variants respond differently <italic>K. pneumoniae</italic> 43816 infection. In addition, it is unclear whether our results with <italic>K. pneumoniae</italic> 43816 will be found with other K2 strains or strains of other serotypes. Genome-wide analyses of <italic>K. pneumoniae</italic> clinical isolates have shown extensive genetic diversity, virulence factors, and pathogenicity (<xref ref-type="bibr" rid="bib44">Holt et al., 2015</xref>; <xref ref-type="bibr" rid="bib24">Deleo et al., 2014</xref>; <xref ref-type="bibr" rid="bib1">Agard et al., 2019</xref>). Furthermore, since neutrophils are not the major player in host defenses against all strains of <italic>K. pneumoniae</italic>, including some multi-drug resistant clinical isolates (<xref ref-type="bibr" rid="bib104">Xiong et al., 2016</xref>; <xref ref-type="bibr" rid="bib103">Xiong et al., 2015</xref>; <xref ref-type="bibr" rid="bib13">Broug-Holub et al., 1997</xref>; <xref ref-type="bibr" rid="bib38">Greenberger et al., 1996</xref>), future studies can use these <italic>K. pneumoniae</italic> strains to probe the role of SKAP2 in neutrophils as well as other hematopoietic cells during <italic>K. pneumoniae</italic> infections. In summary, neutrophils and their production of ROS play a dual role in host health in many disease states from acute infections to autoimmune diseases to cancer (<xref ref-type="bibr" rid="bib43">Hoffmann and Griffiths, 2018</xref>; <xref ref-type="bibr" rid="bib70">Nguyen et al., 2017</xref>), and the crucial function of SKAP2-mediated ROS in murine neutrophils suggests that further analysis of the role of SKAP2 in human health warrants investigation.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>C57BL/6J</td><td>Jackson Laboratory</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>B6.129S5-<italic>Skap2<sup>Gt(VICTR20)21Lex</sup></italic>/Mmjax</td><td>Jackson Laboratory</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/MGI:4353994">MGI:4353994</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>B6.129S-<italic>Cybb<sup>tm1Din</sup></italic>/J</td><td>Jackson Laboratory</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:002365">IMSR_JAX:002365</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>BALB/c <break/>BALB/cAnNTac</td><td>Taconic Laboratory</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_TAC:balb">IMSR_TAC:balb</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>Klebsiella pneumoniae</italic>)</td><td>ATCC 43816 KPPR1</td><td>GenBank <break/>ATCC</td><td>GenBank: CP009208.1</td><td/></tr><tr><td>Antibody</td><td>Rat Anti-Ly6G monoclonal antibody, unconjugated, Clone 1A8</td><td>Fisher Scientific</td><td>BD Biosciences Cat# 551459, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394206">AB_394206</ext-link></td><td>(100 ul of 50 ug/ml)</td></tr><tr><td>Antibody</td><td>Anti-CCR2 (MC21)</td><td>Dr. Matthias Mack <xref ref-type="bibr" rid="bib57">Mack et al., 2001</xref></td><td>Cat# CCR2 (MC21), RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2314128">AB_2314128</ext-link></td><td>(100 ul of 200 ug/ml)</td></tr><tr><td>Antibody</td><td>Rat anti-mouse CD16/CD32 Mouse BD Fc Block</td><td>BD Biosciences</td><td>BD Biosciences Cat# 553142, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_394657">AB_394657</ext-link></td><td>(1:200 dilution)</td></tr><tr><td>Antibody</td><td>Rat monoclonal anti-mouse/human α-CD11b-PE or α-CD11b-PacBlue <break/>(clone M1/70)</td><td>Biolegend</td><td>BioLegend Cat# 101207, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_312790">AB_312790</ext-link> <break/>BioLegend Cat# 101223, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_755985">AB_755985</ext-link></td><td>(1:300 dilution)</td></tr><tr><td>Antibody</td><td>Rat monoclonal anti-mouse α-Ly6G PE-Cy7 <break/>(clone 1A8)</td><td>Biolegend</td><td>BioLegend Cat# 127617, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1877262">AB_1877262</ext-link></td><td>(1:300 dilution)</td></tr><tr><td>Antibody</td><td>Hamster monoclonal anti-mouse α-CD11c-PerCP-Cy5.5 (clone HL3)</td><td>BD Biosciences</td><td>BD Biosciences Cat# 560584, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1727422">AB_1727422</ext-link></td><td>(1:300 dilution)</td></tr><tr><td>Antibody</td><td>Rat monoclonal anti-mouse α-Gr1-FITC or α-Gr1-APC <break/>(clone RB6-8C5)</td><td>BioLegend</td><td>BioLegend Cat# 108411, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313376">AB_313376</ext-link> <break/>BioLegend Cat# 108405, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_313370">AB_313370</ext-link></td><td>(1:300 dilution)</td></tr><tr><td>Antibody</td><td>Rat monoclonal anti-mouse α-Ly6C-AlexaFluor647 <break/>(clone HK1.4)</td><td>BioLegend</td><td>BioLegend Cat# 128010, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1236550">AB_1236550</ext-link></td><td>(1:300 dilution)</td></tr><tr><td>Antibody</td><td>Rabbit polyclonal anti-mouse/human α-SKAP2</td><td>Proteintech</td><td>Proteintech Cat# 12926–1-AP, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2189317">AB_2189317</ext-link></td><td>(1:200 dilution or 1.57 ug/ml)</td></tr><tr><td>Antibody</td><td>rabbit IgG polyclonal isotype antibody</td><td>Proteintech</td><td>Proteintech Cat# 30000–0-AP, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2819035">AB_2819035</ext-link></td><td>(1.57 ug/ml)</td></tr><tr><td>Antibody</td><td>Alexa Fluor 488 goat anti-rabbit secondary antibody</td><td>Thermo Fisher Scientific</td><td>Thermo Fisher Scientific Cat# A-11034, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2576217">AB_2576217</ext-link></td><td>(1:250 dilution)</td></tr><tr><td>Antibody</td><td>Rabbit polyclonal anti-human serum albumin</td><td>Sigma-Aldrich</td><td>Sigma-Aldrich Cat# A0433, <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_257887">AB_257887</ext-link></td><td>(1:400 dilution)</td></tr><tr><td>Antibody</td><td>Rabbit anti-human/mouse Phospho-Src Family (Y416)</td><td>Cell Signaling Technology</td><td>Cell Signaling Technology Cat# 2101, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_331697">AB_331697</ext-link></td><td>(1:500)</td></tr><tr><td>Antibody</td><td>Rabbit anti-human/mouse monoclonal Phospho-Zap-70 (Y319)/Syk (Y352)</td><td>Cell Signaling Technology</td><td>Cell Signaling Technology Cat# 2717, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2218658">AB_2218658</ext-link></td><td valign="top">(1:500)</td></tr><tr><td>Antibody</td><td>Rabbit anti-human/mouse polyclonal Phospho-Pyk2 (Y402)</td><td>Cell Signaling Technology</td><td>Cell Signaling Technology Cat# 3291, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2300530">AB_2300530</ext-link></td><td valign="top">(1:500)</td></tr><tr><td>Antibody</td><td>Rabbit anti-human/mouse polyclonal RhoGDI</td><td>Cell Signaling Technology</td><td>Cell Signaling Technology Cat# 2564, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2274313">AB_2274313</ext-link></td><td valign="top">(1:1000)</td></tr><tr><td>Antibody</td><td>Rabbit anti-human/mouse polyclonal Syk</td><td>Cell Signaling Technology</td><td>Cell Signaling Technology Cat# 2712, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2197223">AB_2197223</ext-link></td><td valign="top">(1:500)</td></tr><tr><td>Antibody</td><td>Rabbit anti-human/mouse polyclonal Pyk2</td><td>Cell Signaling Technology</td><td>Cell Signaling Technology Cat# 3292, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2174097">AB_2174097</ext-link></td><td valign="top">(1:500)</td></tr><tr><td>Antibody</td><td>Goat Anti-rabbit IgG (H+L) (DyLight 800 4X PEG Conjugate)</td><td>Cell Signaling Technology</td><td>Cell Signaling Technology Cat# 5151, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10697505">AB_10697505</ext-link></td><td>(1:20,000)</td></tr><tr><td>Recombinant DNA Reagent</td><td>MSCVneo-HA-ER-Hoxb8</td><td><xref ref-type="bibr" rid="bib99">Wang et al., 2006</xref></td><td>In-house (Sykes lab @ MGH)</td><td/></tr><tr><td>Peptide, recombinant protein</td><td>Stem cell factors</td><td>Cho-SCF</td><td>In-house</td><td/></tr><tr><td>Peptide, recombinant protein</td><td>Recombinant murine Stem cell factors</td><td>Peprotech</td><td>Cat. #: AF-250</td><td>(50 ng/ml)</td></tr><tr><td>Peptide, recombinant protein</td><td>Recombinant murine Interleukin-3</td><td>Peprotech</td><td>Cat. #: 213–13</td><td>(10–50 ng/ml)</td></tr><tr><td>Peptide, recombinant protein</td><td>Recombinant murine Interleukin-6</td><td>Peprotech</td><td>Cat. #: 216–16</td><td>(10 ng/ml)</td></tr><tr><td>Peptide, recombinant protein</td><td>Recombinant human G-CSF</td><td>Peprotech</td><td>Cat. #: 300–23</td><td>(50 ng/ml)</td></tr><tr><td>Peptide, recombinant protein</td><td>Fibronectin human plasma</td><td>Sigma</td><td>Cat. #: F0895</td><td>(10 ug/ml)</td></tr><tr><td>Peptide, recombinant protein</td><td>β-estradiol</td><td>Sigma</td><td>Cat. #: E2758</td><td>(0.5 uM)</td></tr><tr><td>Peptide, recombinant protein</td><td>Firbonectin-like protein polymer genetically engineered</td><td>Sigma Aldrich</td><td>Cat. #: F5022</td><td>(15 ug/ml)</td></tr><tr><td>Peptide, recombinant protein</td><td>Albumin from human serum</td><td>Sigma</td><td>Cat. #: A9511</td><td>(20 ug/ml)</td></tr><tr><td>Chemical compound</td><td>Hexadimethrine bromide (polybrene)</td><td>Sigma Aldrich</td><td>Cat. #: 107689</td><td>(8 ug/ml)</td></tr><tr><td>Commercial assay or kit</td><td>Mouse total MMP9 DuoSet ELISA</td><td>R and D Systems</td><td>Cat. #: DY6718</td><td/></tr><tr><td>Commercial assay or kit</td><td>Mouse neutrophil elastase/ELA2 DuoSet ELISA</td><td>R and D Systems</td><td>Cat. #: DY4517</td><td/></tr><tr><td>Chemical compound</td><td>4-Aminophthalhydrazide (isoluminol)</td><td>Sigma</td><td>Cat. #: A8264</td><td>(50 uM)</td></tr><tr><td>Chemical compound</td><td>Peroxidase from horseradish</td><td>Sigma</td><td>Cat. #: P6782</td><td>(15 U/ml)</td></tr><tr><td>Chemical compound, drug</td><td>PP2</td><td>Selleck</td><td>Cat. #: S7008</td><td>(10 nM)</td></tr><tr><td>Chemical compound, drug</td><td>R406</td><td>Selleck</td><td>Cat. #: S2194</td><td>(2 uM)</td></tr><tr><td>Chemical compound, drug</td><td>Ibrutinib (PCI-32765)</td><td>Selleck</td><td>Cat. #: S2680</td><td>(1 uM)</td></tr><tr><td>Chemical compound, drug</td><td>Gouml 6983, PKC inhibitor</td><td>Abcam</td><td>Cat. #: ab144414</td><td>(10 uM)</td></tr><tr><td>Chemical compound, drug</td><td>U-73122</td><td>Sigma</td><td>Cat. #: U6756</td><td>(1 uM)</td></tr><tr><td>Chemical compound, drug</td><td>U-73433</td><td>Sigma</td><td>Cat. #: U6756</td><td>(1 uM)</td></tr><tr><td>Chemical compound, drug</td><td>G418/Geneticin</td><td>Thermo Scientific</td><td>Cat. #: 10131035</td><td>(1 mg/ml)</td></tr><tr><td>Other</td><td>Immunolon 4HBX 96-well plates</td><td>Fisher Scientific</td><td>Cat. #: 3855</td><td/></tr><tr><td>Other</td><td>Cytochrome c from equine heart</td><td>Sigma</td><td>Cat. #: C7752</td><td>(100 uM)</td></tr><tr><td>Other</td><td>Ficoll-Paque-Plus</td><td>Pharmacia/GE Healthcare</td><td>Cat. #: GE17-1440-02</td><td>(1:1 dilution)</td></tr><tr><td>Other</td><td>Percoll</td><td>Sigma-Aldrich</td><td>Cat. #: P1644</td><td/></tr><tr><td>Other</td><td>e-Myco Mycoplasma PCR Detection Kit</td><td>Bulldog Bio</td><td>Cat. #: 25233</td><td/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals</title><p>BALB/c and C57BL/6J mice were purchased from Taconic Biosciences and Jackson laboratory (Bar Harbor, ME), respectively. Mating pairs of <italic>Cybb-/-</italic> in C57BL/6J background, and <italic>Skap2<sup>+/-</sup></italic> (B6.129S5-<italic>Skap2<sup>Gt(VICTR20)21Lex</sup></italic>/Mmjax) were purchased from Jackson laboratory and bred at Tufts University in the specific pathogen-free facility of Tufts University. Generation of <italic>Skap2-/</italic>- mice in the BALB/c background was previously described (<xref ref-type="bibr" rid="bib93">Togni et al., 2005</xref>; <xref ref-type="bibr" rid="bib2">Alenghat et al., 2012</xref>). <italic>Skap2-/</italic>- mice were genotyped by two independent PCRs using primer sequences: <italic>Skap</italic>Left-forward primer (common for both PCRs), 5’ <named-content content-type="sequence">CAG CTT GCC GAC TTT TCT</named-content>; GTLexVir, 5’<named-content content-type="sequence">GAG GGC TGG ACC GCA TCT GG</named-content>; GT<italic>Skap</italic>Right, 5’<named-content content-type="sequence">CCG CCT CCC ACC CCT CAA TC</named-content> following procedures described from Jackson laboratory and (<xref ref-type="bibr" rid="bib2">Alenghat et al., 2012</xref>). All mice were handled in accordance with protocols approved by the Institutional Animal Care and Use Committee of Tufts University.</p></sec><sec id="s4-2"><title>Mouse intranasal infections</title><p>Mouse infections were carried out as previously described (<xref ref-type="bibr" rid="bib72">Paczosa et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Silver et al., 2019</xref>) with the following modifications. MKP220, streptomycin-resistant derivative of <italic>K. pneumoniae</italic> ATCC43816 strain was used for all infections (<xref ref-type="bibr" rid="bib72">Paczosa et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Silver et al., 2019</xref>). Isoflurane anesthetized mice on a BALB/c background were intranasally infected dropwise with 5 × 10<sup>3</sup> cfu <italic>K. pneumoniae</italic> in 40 μl of sterile PBS, or with PBS (Fisher Scientific) alone. C57BL/6J mice were inoculated retropharyngeally with 5 × 10<sup>3</sup> cfu as previously described (<xref ref-type="bibr" rid="bib72">Paczosa et al., 2020</xref>). This change in infection route was because we have found that if delivered intranasally, C57BL/6J mice will rapidly dispel the inoculum through their nose and mouth resulting in inconsistent infection. Mice were euthanized using CO<sub>2</sub> asphyxiation at the indicated time points after infection. Lungs were collected into sterile PBS, weighed, and aseptically homogenized by pushing the tissue through a 70 μM cell strainer. For bacterial burden analyses, serially diluted homogenates were plated on L-agar and incubated at 37°C overnight to determine CFU/g lung. For depletion of neutrophils or iMOs, mice were intraperitoneally injecting 100 μl of 50 μg/ml α-Ly6G antibody (clone: 1A8, Fisher Scientific), or 100 μl of 200 μg/ml α-MC21 antibody 16 hr pre-infection. Depletion efficiency was measured by flow cytometry as described below. Collection of bronchoalveolar lavage was conducted as previously described (<xref ref-type="bibr" rid="bib87">Silver et al., 2019</xref>).</p></sec><sec id="s4-3"><title>Bone marrow chimeras</title><p>4–5 week-old BALB/c and <italic>Skap2-/</italic>- mice received 100 mg/kg/24 hr SulfaTrim available ad libitum in drinking water for a week prior to and a week following whole body irradiation. Mice were lethally irradiated with 2 doses of 4.5 G<italic>γ</italic> with a 3–4 hr interval between doses. The next day, each mouse intravenously received 100 μl of sterile PBS containing 5 × 10<sup>6</sup> BM cells from either BALB/c or <italic>Skap2-/</italic>- donor mice (7–15 week-old) and were infected with <italic>K. pneumoniae</italic> 4–5 weeks later.</p></sec><sec id="s4-4"><title>Immunohistochemistry</title><p>For histological studies, lungs from mock or <italic>K. pneumoniae</italic>-infected mice were perfused through a tracheal incision using 4% formaldehyde (MP Biomedicals), removed, and incubated in fresh 4% formaldehyde overnight at room temperature (RT). Excess fatty tissues were removed, and lungs were placed in histology cassettes for processing by the Tufts Animal Pathology Core. Tissues were embedded in paraffin and 7 μM thick sections were sliced and stained with hematoxylin and eosin (HE). Sections were blindly scored for number of areas of leukocyte infiltration and detectable bacteria by 4–7 individuals with at least 3 lung sections per mouse using light microscopy. Three PBS-inoculated and 5 <italic>K. pneumoniae</italic>-infected mice were scored per genotype. Tissues were imaged using an Echo Revolve R4 microscope in the upright brightfield configuration at 4x (NA 0.13) or 40x (NA 0.75) magnification and acquired at RT using a 12 MP CMOS color camera and the Echo Revolve built-in software.</p></sec><sec id="s4-5"><title>Degranulation</title><p>After passage of lung tissues through 70 μm strainers, the cell suspensions were centrifuged at 13,000 <italic>x g</italic> for 10 min at 4°C. Supernatants were then transferred into new Eppendorf tubes for measurement of release of matrix metalloproteinase (MMP-9), and neutrophil elastase (ELA-2) by DuoSet ELISA kits (R and D Systems) per manufacturer’s protocols.</p></sec><sec id="s4-6"><title>Flow-cytometry analysis of lung cells</title><p>After passage of lung tissues through a 70 μm strainer, cell suspensions were treated with 1 mg/ml Collagenase D (ThermoFisher Scientific) for 1 hr at 37°C, and then with 1X Pharm Lyse (Fisher Scientific) for 5 min at 4°C. Cells were resuspended in ice-cold fluorescence-activated cell sorter (FACS) buffer (PBS containing 1% FBS), and blocked with rat anti-mouse CD16/CD32 (Mouse BD Fc Block BD Biosciences) for 10 min at 4°C. For time courses, cells were stained with α-CD11b-PE (BioLegend), α-Ly6G PE-Cy7 (BioLegend), α-CD11c-PerCP-Cy5.5 (BD Biosciences), and α-Gr1-FITC (BioLegend) for analysis of neutrophils (CD11b<sup>+</sup> Ly6G<sup>+</sup>), alveolar macrophages (CD11b<sup>int</sup> CD11c<sup>hi</sup>), resident monocytes (CD11b<sup>+</sup> Gr1<sup>lo</sup>), and dendritic cells (CD11b<sup>hi</sup> CD11c<sup>hi</sup>). For bone marrow chimeric and depletion experiments, lung cells were stained with α-CD11b-PacBlue (BioLegend), α-Ly6G-PE-Cy7 (BioLegend), α-Gr1-APC (BioLegend), and α-Ly6C-AlexaFluor647 (BioLegend) for analysis of neutrophils and inflammatory monocytes as indicated in figure legends. For some experiments, cells were fixed with 4% formaldehyde, permeabilized with 0.1% saponin, and intracellularly stained with α-SKAP2 (Proteintech) or rabbit IgG polyclonal isotype antibody (Proteintech), followed by goat anti-rabbit AlexaFluor488 secondary antibody (ThermoFisher Scientific). Data were collected by a BD LSRII, and analyzed with FlowJo (version 10.1).</p></sec><sec id="s4-7"><title>Bone marrow neutrophil isolation</title><p>Mouse BM neutrophils were isolated as previously described (<xref ref-type="bibr" rid="bib81">Rolán et al., 2013</xref>) with the following modifications. Neutrophils were isolated using a three step Percoll density gradient (55%, 65%, and 75%), and centrifuged at 480 <italic>x g</italic> for 30 min at 26°C without applying the break. Neutrophils were collected at the 65–75% interface, resuspended in HBSS without Ca<sup>2+</sup> or Mg<sup>2+</sup> (HBSS-), then centrifuged at 250 <italic>x g</italic> for 5 min at RT to wash and pellet the cells. Supernatants were removed and cells were resuspended in HBSS- and centrifuged for a total of three washes. Neutrophils were rested at RT for one hour, resuspended in HBSS with Ca<sup>2+</sup> and Mg<sup>2+</sup> (HBSS+) to the desired concentration, incubated at RT for 20 min, and then shifted to 37°C for 10 min prior to the experiment. The purity of neutrophil preparations was verified by staining an aliquot of the cells with α-CD11b-PacBlu, α-Ly6G-PE-Cy7, and α-Gr1-APC and analyzed by flow cytometry.</p></sec><sec id="s4-8"><title>Generating HoxB8-immortalized GMP cells</title><p>Immortalization of murine BM cells with ER-HoxB8 was done as previously described (<xref ref-type="bibr" rid="bib99">Wang et al., 2006</xref>) with the following modifications. Bone marrow stem cells were collected from the tibias and femurs of mice and passed through a 40 μm filter. Cells were layered over Ficoll-Paque-Plus (Pharmacia), and centrifuged at 400 <italic>x g</italic> for 25 min at RT without applying the break to enrich for mononuclear cells. These cells were incubated in a 6-well tissue culture plate (Greiner Bio-One) for 24 hr at 37°C with 5% CO<sub>2</sub> prior to the retroviral transduction in complete RPMI, cRPMI (RPMI-1640 with 10% FBS, 2 mM L-glutamine, and 100U penicillin and 0.1 mg/ml streptomycin), supplemented with 10 ng/ml stem cell factor (SCF), 10 ng/ml interleukin-3 (IL-3), and 10 ng/ml interleukin-6 (IL-6). The next day, non-adherent cells were harvested and 5 × 10<sup>5</sup> cells in 500 μl of cRPMI were plated onto a 12-well tissue culture plate (Corning) coated with 10 μg/ml human fibronectin (Sigma). Retroviral supernatant (MSCVneo-HA-ER-Hoxb8) was applied in the presence of 8 μg/ml polybrene and the plates were centrifuged for ‘spinoculation’ at 1000 <italic>x g</italic> for 90 min at RT. Following spin infection, cells were maintained in cRPMI supplemented with 0.5 μM beta-estradiol (Sigma, E2) and conditioned media containing approximately 50 ng/ml SCF (SCF + E2 cRPMI). Cells were maintained for 3–4 weeks to select for ER-HoxB8-carrying granulocyte-monocyte progenitor cells. Uninfected cells were maintained alongside as controls and all died by 4 weeks. To confirm the identify of cell lines, we assessed for SKAP2 protein expression by intracellular staining or western blotting. Mycoplasma testing of cultured lines was conducted at 3–6 month intervals using e-Myco Mycoplasma PCR Detection Kit (Bulldog Bio).</p></sec><sec id="s4-9"><title>Differentiating neutrophils from Hoxb8-immortalized stem cell lines</title><p>ER-HoxB8 stem cell lines were grown in E2 + SCF cRPMI. Differentiation into neutrophils was done as previously described (<xref ref-type="bibr" rid="bib99">Wang et al., 2006</xref>; <xref ref-type="bibr" rid="bib75">Pelletier et al., 2017</xref>) with the following modifications. Aliquots of ER-HoxB8 progenitors were washed 3 times in PBS and cultured in E2-free cRPMI media supplemented with ~50 ng/ml SCF, IL-3, and GCSF for two days. Cells were then restimulated with 50 ng/ml GCSF for another 48 hr. At this point, cells were differentiated and termed DIV neutrophils. DIV neutrophils were collected, pelleted at 250 <italic>x g</italic> for 5 min at 4°C, re-suspended in HBSS- and rested for 1 hr at RT. DIV neutrophils were re-suspended in HBSS+ to the desired concentration, incubated at RT for 20 min, and then shifted to 37°C for 10 min for functional assays.</p><p>DAPI staining and flow cytometry were performed to confirm that &gt;90% of cells were neutrophils. An aliquot of 1 × 10<sup>5</sup> BM and DIV neutrophils were spun onto microscope slide using Shannon Cytospin 3, fixed with 4% formaldehyde, stained with DAPI (ThermoFisher Scientific), and mounted using ProLong Gold antifade reagent (Invitrogen). Cell morphology was imaged at 60X by an Echo Revolve R4 microscope in the upright fluorescent configuration. Aliquots of cells were resuspended in cold FACS buffer and blocked with Mouse BD Fc Block (BioLegend) for 10 min at 4°C. Cells were then stained with α-CD11b-PacBlu, α-Ly6G-PE-Cy7, and α-cKit-PE, and then fixed with 4% formaldehyde prior to analysis. Viability was assessed using trypan blue (Gibco) exclusion test immediately prior to functional studies to confirm that &gt;85% of cells were live and all counts were based on live cells. In addition, an ATP-based assay, Promega CellTiter-Glo Luminescent Cell viability Assay, was conducted during the time course of several experiments to assess viability per instructor’s instructions (Promega) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E-F</xref>).</p></sec><sec id="s4-10"><title>Klebsiella-neutrophil binding assay</title><p>Neutrophils (1 × 10<sup>5</sup> cells/well) and green fluorescent protein (GFP)-labeled <italic>K. pneumoniae</italic> (MOI 40) were added to non-tissue-treated 96-well plates (CellTreat), centrifuged at 250 x <italic>g</italic> for 3 min, and then incubated for 30 min at 37°C with 5% CO<sub>2</sub> for 15 or 30 min. Cells were then harvested, centrifuged at 250 x <italic>g</italic> for 5 min, and resuspended in 200 ul/well ice-cold FACS buffer; this was repeated for a total of 3 washes. Cells were then fixed with 4% formaldehyde, and nuclei were stained with DAPI. The percentage of <italic>K. pneumoniae</italic>-associated neutrophils was determined by flow cytometry using uninfected neutrophils as control.</p></sec><sec id="s4-11"><title>Gentamicin protection assay</title><p><italic>K. pneumoniae</italic> MKP220 and a isogenic non-encapsulated <italic>ΔcpsB</italic> strain (<xref ref-type="bibr" rid="bib72">Paczosa et al., 2020</xref>; <xref ref-type="bibr" rid="bib87">Silver et al., 2019</xref>) were grown overnight in LB media at 37°C with aeration, and the next day diluted 1:40 into fresh LB media and grown for an additional 2 hr at 37°C with aeration. The <italic>Y. pseudotuberculosis</italic> YPIII <italic>ΔyscNU</italic> strain (<xref ref-type="bibr" rid="bib5">Balada-Llasat and Mecsas, 2006</xref>) was grown in 2XYT at 26°C with aeration. <italic>K. pneumoniae</italic> and <italic>Y. pseudotuberculosis</italic> were then used to infect 1 × 10<sup>5</sup> DIV neutrophils at an MOI of 10 for 30 min at 37°C in the presence of 5% CO<sub>2</sub> in 96-well 4HBX plates pre-coated with 10% FBS, and then 100 μg/ml gentamicin was added to wells for 1 hr at 37°C to kill extracellular bacteria. Control FBS-coated wells contained bacteria but no neutrophils and were not treated with gentamicin (non-gentamicin-treated wells). All following steps were conducted at 4°C. Cold PBS was added to the wells; plates were centrifuged at 250 <italic>x g</italic> for 5 min, and all media were gently removed; this was repeated for a total of four washes. All wells were treated with 0.1% Triton X-100 (Sigma-Aldrich) for 10 min at 4°C, and then serially diluted and plated to quantify surviving bacteria. The percent of phagocytosis was calculated as (# of bacteria with neutrophils from gentamicin-treated wells) <bold>/</bold> (# of bacteria from non-gentamicin-treated wells).</p></sec><sec id="s4-12"><title>Neutrophil ROS assays</title><p>High-bound tissue-treated 4HBX 96-well plates (Fisher Scientific) were used for all ROS assays. Plates were prepared as follows. For integrin activation, wells were coated with 15 μg/ml poly-RGD (Sigma) for 2 hr at 37°C or overnight at RT. For Fcγ receptor activation by IgG immune complexes (IC), wells were coated with 20 μg/ml human serum albumin (Sigma) for 1 hr, washed twice with PBS, blocked with 10% FBS for 30 min, washed twice with PBS, and incubated with anti-human serum albumin (Sigma) at 1:400 dilution in 10% FBS for 1 hr at 37°C. Control wells were coated with 10% FBS for 30 min at 37°C. All wells were washed twice with PBS prior to use. For experiments with <italic>K. pneumoniae</italic>, wells were coated with 10% FBS for 30 min at 37°C and washed twice with PBS prior to use. For all ROS assays, 100 nM of PMA was used as positive control. To evaluate whether <italic>Skap2-/</italic>- neutrophils generated ROS after infection with another species of bacteria, a <italic>Y. pseudotuberculosis</italic> YPIII type 3 secretion mutant, Δ<italic>yscF</italic> was used (<xref ref-type="bibr" rid="bib37">Green et al., 2016</xref>).</p><p>To detect RGD or IgG IC-stimulated ROS, superoxide detection by cytochrome C (Sigma) was performed as previously described (<xref ref-type="bibr" rid="bib55">Lowell et al., 1996</xref>) with the following modifications. Cytochrome C was added to each well at a final concentration of 100 μM and 1 × 10<sup>5</sup> neutrophils were added to each well coated with either FBS or ligand. Absorbance at 490 nm and 550 nm were recorded at 37°C using Biotek Synergy HT. Superoxide concentration was calculated by (OD<sub>550</sub>-OD<sub>490</sub>) x (2.11 × 10<sup>4</sup> M<sup>−1</sup>cm<sup>−1</sup>), which is the extinction coefficient of cytochrome C (<xref ref-type="bibr" rid="bib22">Dahlgren et al., 2007</xref>). Total superoxide production was calculated by the sum of the area under the curves for the indicated time.</p><p>To detect ROS production following <italic>K. pneumoniae</italic> exposure, isoluminol was performed as previously described (<xref ref-type="bibr" rid="bib48">Kobayashi et al., 2016</xref>; <xref ref-type="bibr" rid="bib22">Dahlgren et al., 2007</xref>) with the following modifications. Neutrophils resuspended in HBSS+, rested at RT for 30 min, were loaded with 50 μM isoluminol (Sigma) and 15 U/ml HRP (Sigma), added to a 96-well plate at 1 × 10<sup>5</sup> cells/well, and incubated at 37°C for 10 min. <italic>K. pneumoniae</italic> (grown as described in gentamicin protection assays) were then added to wells at a MOI of 2.5 or 5, and the plate was centrifuged at 500 <italic>x g</italic> for 3 min at 4°C. For inhibitor studies, following isoluminol and HRP loading, DIV neutrophils were pre-treated with 10 nM PP2 (Selleck Chemical), 2 μM R406 (Selleck Chemical), 1 μM Ibrutinib (Selleck Chemical), 10 μM Go 6983 (Abcam), 1 μM U-73122 (Sigma), 1 μM U-73433 (Sigma), or DMSO (1:10,000 final concentration, Sigma) vehicle control for 10 min at 37°C with 5% CO<sub>2</sub>. A BioTek Synergy HT late reader was used to detect chemiluminescence (RLU). Total ROS (total RLU) production was calculated by the sum of the area under the curves for the indicated time in figure legends.</p></sec><sec id="s4-13"><title>Western blot analysis</title><p>DIV neutrophils (7.5 × 10<sup>5</sup> cells/well) in HBSS+ were plated onto 96-well 4HBX plates coated with 10% FBS. <italic>K. pneumoniae</italic> was added at MOI 40 and spun at 250 <italic>x g</italic> for 2 min. Cells were incubated at 37°C in presence of 5% CO<sub>2</sub> for 10 or 15 min, lysed in 1X Novex buffer (4X stock: 40% sucrose, 6.82% Tris-Base, 6.66% Tris-HCL, 8% SDS, 0.06% EDTA, 0.075% Bromophenol Blue, 2.5 mM NaVO<sub>4</sub>, 100 mM DTT) and 5–7.5 × 10<sup>5</sup> cells equivalents were resolved on 4–12% NuPAGE gel (Invitrogen) in MOPS buffer (10.5% MOPS, 6% Tris-Base, 5% SDS, 0.3% EDTA). Proteins were transferred to Immobilon-FL PVDF (Millipore Sigma) and subjected to western blot analysis using antibodies at a dilution of 1:500 unless otherwise indicated. Antibodies to phosphorylated proteins include Src Family-Y416 (Cell Signaling Technology), Syk-Y352 (Cell Signaling Technology) and Pyk2-Y402 (Cell Signaling Technology). All blots were also probed with RhoGDI (Cell Signaling Technology) at a dilution of 1:1000 as loading control. Secondary LI-COR goat anti-mouse IRDye 800 CW (Cell Signaling Technology) and goat anti-rabbit IRDye 800 CW (Cell Signaling Technology) were used at a dilution of 1:20,000. The Odyssey CLx LI-COR system was used to develop the blots and IS Image Studio was used for analysis and quantification of bands. Blots were then stripped with 7M Guanine Hydrochloride (Fisher Scientific) by incubating at 56°C for 30 min with shaking, washed 3 times in 1x TBST (0.1% Tween-20 in 1x TBS), and reprobed with antibodies for total proteins against Syk and Pyk2 (Cell Signaling Technology). The normalized protein level of pSFKs was calculated by taking the ratio of phosphorylated protein to RhoGDI loading control. The normalized protein levels of pSyk and pPyk2 were calculated by first taking the ratio of phosphorylated to total protein and then normalizing to the RhoGDI loading control. Normalized phospho-protein levels were used to calculate the fold change to unstimulated (0 min) control within each group, or to unstimulated control of WT (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). In addition, the relative induction of phosphorylation in unstimulated controls was determined by dividing the fold change of each experiment by the average of the three experiments. Fold change was log transformed and subjected to statistical analysis.</p></sec><sec id="s4-14"><title>Statistics</title><p>Differences between the groups were evaluated by one-way ANOVA or two-way ANOVA with either Tukey’s or Sidak’s post-test, where appropriate (GraphPad Software version 7). Log-transformed values were used for determining significance in experiments measuring CFU.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This work was supported by NIH NIAID R01 AI113166 awarded to JM; LS was supported by NIH 4T32AI007422. The authors declare no competing financial interests. We thank Alyssa Fasciano, Anne McCabe, Rebecca Silver, Yoelkys Morales, Erin Green, Michelle Paczosa, Alexander Poltorak, Miles Duncan, and Maria-Cristina Seminario for critically reading the manuscript and/or for helpful scientific and technical discussions.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Supervision, Funding acquisition, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experimental procedures followed NIH guidelines. All mice were handled in accordance with protocols (B2018-10) approved by the Institutional Animal Care and Use Committee (IACUC) of Tufts University.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Figure data files.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-56656-data1-v2.zip"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Raw values of western blot analysis for phopho-Src Family Kinases, phospho-Syk, phospho-Pyk2.</title><p>WT and <italic>Skap2-/-</italic> (KO) DIV neutrophils were infected with wild-type <italic>Kp</italic>, or stimulated with IgG IC (as positive control) for 10 min at 37°C. Lysates were prepared and analyzed by western blot for phosphoproteins, total proteins, and RhoGDI as indicated. Quantification of protein level was assessed using Licor.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-56656-supp1-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-56656-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated and analyzed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agard</surname> <given-names>MJ</given-names></name><name><surname>Ozer</surname> <given-names>EA</given-names></name><name><surname>Morris</surname> <given-names>AR</given-names></name><name><surname>Piseaux</surname> <given-names>R</given-names></name><name><surname>Hauser</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A genomic approach to identify <italic>Klebsiella pneumoniae</italic> and <italic>Acinetobacter baumannii</italic> strains with enhanced competitive fitness in the lungs during multistrain pneumonia</article-title><source>Infection and Immunity</source><volume>87</volume><elocation-id>e00871-18</elocation-id><pub-id pub-id-type="doi">10.1128/IAI.00871-18</pub-id><pub-id pub-id-type="pmid">30936161</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alenghat</surname> <given-names>FJ</given-names></name><name><surname>Baca</surname> <given-names>QJ</given-names></name><name><surname>Rubin</surname> <given-names>NT</given-names></name><name><surname>Pao</surname> <given-names>LI</given-names></name><name><surname>Matozaki</surname> <given-names>T</given-names></name><name><surname>Lowell</surname> <given-names>CA</given-names></name><name><surname>Golan</surname> <given-names>DE</given-names></name><name><surname>Neel</surname> <given-names>BG</given-names></name><name><surname>Swanson</surname> <given-names>KD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Macrophages require Skap2 and sirpα for integrin-stimulated cytoskeletal rearrangement</article-title><source>Journal of Cell Science</source><volume>125</volume><fpage>5535</fpage><lpage>5545</lpage><pub-id pub-id-type="doi">10.1242/jcs.111260</pub-id><pub-id pub-id-type="pmid">22976304</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachman</surname> <given-names>MA</given-names></name><name><surname>Breen</surname> <given-names>P</given-names></name><name><surname>Deornellas</surname> <given-names>V</given-names></name><name><surname>Mu</surname> <given-names>Q</given-names></name><name><surname>Zhao</surname> <given-names>L</given-names></name><name><surname>Wu</surname> <given-names>W</given-names></name><name><surname>Cavalcoli</surname> <given-names>JD</given-names></name><name><surname>Mobley</surname> <given-names>HL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genome-Wide identification of Klebsiella pneumoniae fitness genes during lung infection</article-title><source>mBio</source><volume>6</volume><elocation-id>e00775</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00775-15</pub-id><pub-id pub-id-type="pmid">26060277</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagaitkar</surname> <given-names>J</given-names></name><name><surname>Matute</surname> <given-names>JD</given-names></name><name><surname>Austin</surname> <given-names>A</given-names></name><name><surname>Arias</surname> <given-names>AA</given-names></name><name><surname>Dinauer</surname> <given-names>MC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Activation of neutrophil respiratory burst by fungal particles requires phosphatidylinositol 3-phosphate binding to p40(phox) in humans but not in mice</article-title><source>Blood</source><volume>120</volume><fpage>3385</fpage><lpage>3387</lpage><pub-id pub-id-type="doi">10.1182/blood-2012-07-445619</pub-id><pub-id pub-id-type="pmid">23086626</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balada-Llasat</surname> <given-names>JM</given-names></name><name><surname>Mecsas</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Yersinia has a tropism for B and T cell zones of lymph nodes that is independent of the type III secretion system</article-title><source>PLOS Pathogens</source><volume>2</volume><elocation-id>e86</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0020086</pub-id><pub-id pub-id-type="pmid">16948531</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname> <given-names>JC</given-names></name><name><surname>Clayton</surname> <given-names>DG</given-names></name><name><surname>Concannon</surname> <given-names>P</given-names></name><name><surname>Akolkar</surname> <given-names>B</given-names></name><name><surname>Cooper</surname> <given-names>JD</given-names></name><name><surname>Erlich</surname> <given-names>HA</given-names></name><name><surname>Julier</surname> <given-names>C</given-names></name><name><surname>Morahan</surname> <given-names>G</given-names></name><name><surname>Nerup</surname> <given-names>J</given-names></name><name><surname>Nierras</surname> <given-names>C</given-names></name><name><surname>Plagnol</surname> <given-names>V</given-names></name><name><surname>Pociot</surname> <given-names>F</given-names></name><name><surname>Schuilenburg</surname> <given-names>H</given-names></name><name><surname>Smyth</surname> <given-names>DJ</given-names></name><name><surname>Stevens</surname> <given-names>H</given-names></name><name><surname>Todd</surname> <given-names>JA</given-names></name><name><surname>Walker</surname> <given-names>NM</given-names></name><name><surname>Rich</surname> <given-names>SS</given-names></name><collab>Type 1 Diabetes Genetics Consortium</collab></person-group><year iso-8601-date="2009">2009</year><article-title>Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes</article-title><source>Nature Genetics</source><volume>41</volume><fpage>703</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1038/ng.381</pub-id><pub-id pub-id-type="pmid">19430480</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batra</surname> <given-names>S</given-names></name><name><surname>Cai</surname> <given-names>S</given-names></name><name><surname>Balamayooran</surname> <given-names>G</given-names></name><name><surname>Jeyaseelan</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Intrapulmonary administration of leukotriene B(4) augments neutrophil accumulation and responses in the lung to <italic>Klebsiella</italic> infection in CXCL1 knockout mice</article-title><source>The Journal of Immunology</source><volume>188</volume><fpage>3458</fpage><lpage>3468</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1101985</pub-id><pub-id pub-id-type="pmid">22379035</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bengoechea</surname> <given-names>JA</given-names></name><name><surname>Sa Pessoa</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title><italic>Klebsiella pneumoniae</italic> infection biology: living to counteract host defences</article-title><source>FEMS Microbiology Reviews</source><volume>43</volume><fpage>123</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1093/femsre/fuy043</pub-id><pub-id pub-id-type="pmid">30452654</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname> <given-names>DS</given-names></name><name><surname>Marie-Cardine</surname> <given-names>A</given-names></name><name><surname>Schraven</surname> <given-names>B</given-names></name><name><surname>Bliska</surname> <given-names>JB</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages</article-title><source>Cellular Microbiology</source><volume>2</volume><fpage>401</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1046/j.1462-5822.2000.00061.x</pub-id><pub-id pub-id-type="pmid">11207596</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boras</surname> <given-names>M</given-names></name><name><surname>Volmering</surname> <given-names>S</given-names></name><name><surname>Bokemeyer</surname> <given-names>A</given-names></name><name><surname>Rossaint</surname> <given-names>J</given-names></name><name><surname>Block</surname> <given-names>H</given-names></name><name><surname>Bardel</surname> <given-names>B</given-names></name><name><surname>Van Marck</surname> <given-names>V</given-names></name><name><surname>Heitplatz</surname> <given-names>B</given-names></name><name><surname>Kliche</surname> <given-names>S</given-names></name><name><surname>Reinhold</surname> <given-names>A</given-names></name><name><surname>Lowell</surname> <given-names>C</given-names></name><name><surname>Zarbock</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Skap<sub>2</sub> is required for β2 integrin-mediated neutrophil recruitment and functions</article-title><source>Journal of Experimental Medicine</source><volume>214</volume><fpage>851</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1084/jem.20160647</pub-id><pub-id pub-id-type="pmid">28183734</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bortoletto</surname> <given-names>P</given-names></name><name><surname>Lyman</surname> <given-names>K</given-names></name><name><surname>Camacho</surname> <given-names>A</given-names></name><name><surname>Fricchione</surname> <given-names>M</given-names></name><name><surname>Khanolkar</surname> <given-names>A</given-names></name><name><surname>Katz</surname> <given-names>BZ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Chronic granulomatous disease: a large, Single-center US experience</article-title><source>The Pediatric Infectious Disease Journal</source><volume>34</volume><fpage>1110</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1097/INF.0000000000000840</pub-id><pub-id pub-id-type="pmid">26181896</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braselmann</surname> <given-names>S</given-names></name><name><surname>Taylor</surname> <given-names>V</given-names></name><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Sylvain</surname> <given-names>C</given-names></name><name><surname>Baluom</surname> <given-names>M</given-names></name><name><surname>Qu</surname> <given-names>K</given-names></name><name><surname>Herlaar</surname> <given-names>E</given-names></name><name><surname>Lau</surname> <given-names>A</given-names></name><name><surname>Young</surname> <given-names>C</given-names></name><name><surname>Wong</surname> <given-names>BR</given-names></name><name><surname>Lovell</surname> <given-names>S</given-names></name><name><surname>Sun</surname> <given-names>T</given-names></name><name><surname>Park</surname> <given-names>G</given-names></name><name><surname>Argade</surname> <given-names>A</given-names></name><name><surname>Jurcevic</surname> <given-names>S</given-names></name><name><surname>Pine</surname> <given-names>P</given-names></name><name><surname>Singh</surname> <given-names>R</given-names></name><name><surname>Grossbard</surname> <given-names>EB</given-names></name><name><surname>Payan</surname> <given-names>DG</given-names></name><name><surname>Masuda</surname> <given-names>ES</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation</article-title><source>Journal of Pharmacology and Experimental Therapeutics</source><volume>319</volume><fpage>998</fpage><lpage>1008</lpage><pub-id pub-id-type="doi">10.1124/jpet.106.109058</pub-id><pub-id pub-id-type="pmid">16946104</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broug-Holub</surname> <given-names>E</given-names></name><name><surname>Toews</surname> <given-names>GB</given-names></name><name><surname>van Iwaarden</surname> <given-names>JF</given-names></name><name><surname>Strieter</surname> <given-names>RM</given-names></name><name><surname>Kunkel</surname> <given-names>SL</given-names></name><name><surname>Paine</surname> <given-names>R</given-names></name><name><surname>Standiford</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival</article-title><source>Infection and Immunity</source><volume>65</volume><fpage>1139</fpage><lpage>1146</lpage><pub-id pub-id-type="doi">10.1128/IAI.65.4.1139-1146.1997</pub-id><pub-id pub-id-type="pmid">9119443</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bureau</surname> <given-names>JF</given-names></name><name><surname>Cassonnet</surname> <given-names>P</given-names></name><name><surname>Grange</surname> <given-names>L</given-names></name><name><surname>Dessapt</surname> <given-names>J</given-names></name><name><surname>Jones</surname> <given-names>L</given-names></name><name><surname>Demeret</surname> <given-names>C</given-names></name><name><surname>Sakuntabhai</surname> <given-names>A</given-names></name><name><surname>Jacob</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome</article-title><source>Oncotarget</source><volume>9</volume><fpage>13102</fpage><lpage>13115</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.24424</pub-id><pub-id pub-id-type="pmid">29568343</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>S</given-names></name><name><surname>Batra</surname> <given-names>S</given-names></name><name><surname>Lira</surname> <given-names>SA</given-names></name><name><surname>Kolls</surname> <given-names>JK</given-names></name><name><surname>Jeyaseelan</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>CXCL1 regulates pulmonary host defense to <italic>Klebsiella</italic> infection via CXCL2, CXCL5, NF-kappaB, and MAPKs</article-title><source>Journal of Immunology</source><volume>185</volume><fpage>6214</fpage><lpage>6225</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0903843</pub-id><pub-id pub-id-type="pmid">20937845</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carsetti</surname> <given-names>L</given-names></name><name><surname>Laurenti</surname> <given-names>L</given-names></name><name><surname>Gobessi</surname> <given-names>S</given-names></name><name><surname>Longo</surname> <given-names>PG</given-names></name><name><surname>Leone</surname> <given-names>G</given-names></name><name><surname>Efremov</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Phosphorylation of the activation loop tyrosines is required for sustained syk signaling and growth factor-independent B-cell proliferation</article-title><source>Cellular Signalling</source><volume>21</volume><fpage>1187</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2009.03.007</pub-id><pub-id pub-id-type="pmid">19296913</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Eddens</surname> <given-names>T</given-names></name><name><surname>Trevejo-Nunez</surname> <given-names>G</given-names></name><name><surname>Way</surname> <given-names>EE</given-names></name><name><surname>Elsegeiny</surname> <given-names>W</given-names></name><name><surname>Ricks</surname> <given-names>DM</given-names></name><name><surname>Garg</surname> <given-names>AV</given-names></name><name><surname>Erb</surname> <given-names>CJ</given-names></name><name><surname>Bo</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Lee</surname> <given-names>JS</given-names></name><name><surname>Gaffen</surname> <given-names>SL</given-names></name><name><surname>Kolls</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>IL-17 receptor signaling in the lung epithelium is required for mucosal chemokine gradients and pulmonary host defense against K. pneumoniae</article-title><source>Cell Host &amp; Microbe</source><volume>20</volume><fpage>596</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.10.003</pub-id><pub-id pub-id-type="pmid">27923703</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>JY</given-names></name><name><surname>McCormick</surname> <given-names>B</given-names></name><name><surname>Mazelyte</surname> <given-names>G</given-names></name><name><surname>Michael</surname> <given-names>M</given-names></name><name><surname>Vermeren</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>HoxB8 neutrophils replicate fcγ receptor and integrin-induced neutrophil signaling and functions</article-title><source>Journal of Leukocyte Biology</source><volume>105</volume><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1002/JLB.1AB0618-232R</pub-id><pub-id pub-id-type="pmid">30211955</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Condliffe</surname> <given-names>AM</given-names></name><name><surname>Davidson</surname> <given-names>K</given-names></name><name><surname>Anderson</surname> <given-names>KE</given-names></name><name><surname>Ellson</surname> <given-names>CD</given-names></name><name><surname>Crabbe</surname> <given-names>T</given-names></name><name><surname>Okkenhaug</surname> <given-names>K</given-names></name><name><surname>Vanhaesebroeck</surname> <given-names>B</given-names></name><name><surname>Turner</surname> <given-names>M</given-names></name><name><surname>Webb</surname> <given-names>L</given-names></name><name><surname>Wymann</surname> <given-names>MP</given-names></name><name><surname>Hirsch</surname> <given-names>E</given-names></name><name><surname>Ruckle</surname> <given-names>T</given-names></name><name><surname>Camps</surname> <given-names>M</given-names></name><name><surname>Rommel</surname> <given-names>C</given-names></name><name><surname>Jackson</surname> <given-names>SP</given-names></name><name><surname>Chilvers</surname> <given-names>ER</given-names></name><name><surname>Stephens</surname> <given-names>LR</given-names></name><name><surname>Hawkins</surname> <given-names>PT</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils</article-title><source>Blood</source><volume>106</volume><fpage>1432</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-03-0944</pub-id><pub-id pub-id-type="pmid">15878979</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coxon</surname> <given-names>A</given-names></name><name><surname>Rieu</surname> <given-names>P</given-names></name><name><surname>Barkalow</surname> <given-names>FJ</given-names></name><name><surname>Askari</surname> <given-names>S</given-names></name><name><surname>Sharpe</surname> <given-names>AH</given-names></name><name><surname>von Andrian</surname> <given-names>UH</given-names></name><name><surname>Arnaout</surname> <given-names>MA</given-names></name><name><surname>Mayadas</surname> <given-names>TN</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation</article-title><source>Immunity</source><volume>5</volume><fpage>653</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(00)80278-2</pub-id><pub-id pub-id-type="pmid">8986723</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname> <given-names>F</given-names></name><name><surname>Achuthan</surname> <given-names>P</given-names></name><name><surname>Akanni</surname> <given-names>W</given-names></name><name><surname>Allen</surname> <given-names>J</given-names></name><name><surname>Amode</surname> <given-names>MR</given-names></name><name><surname>Armean</surname> <given-names>IM</given-names></name><name><surname>Bennett</surname> <given-names>R</given-names></name><name><surname>Bhai</surname> <given-names>J</given-names></name><name><surname>Billis</surname> <given-names>K</given-names></name><name><surname>Boddu</surname> <given-names>S</given-names></name><name><surname>Cummins</surname> <given-names>C</given-names></name><name><surname>Davidson</surname> <given-names>C</given-names></name><name><surname>Dodiya</surname> <given-names>KJ</given-names></name><name><surname>Gall</surname> <given-names>A</given-names></name><name><surname>Girón</surname> <given-names>CG</given-names></name><name><surname>Gil</surname> <given-names>L</given-names></name><name><surname>Grego</surname> <given-names>T</given-names></name><name><surname>Haggerty</surname> <given-names>L</given-names></name><name><surname>Haskell</surname> <given-names>E</given-names></name><name><surname>Hourlier</surname> <given-names>T</given-names></name><name><surname>Izuogu</surname> <given-names>OG</given-names></name><name><surname>Janacek</surname> <given-names>SH</given-names></name><name><surname>Juettemann</surname> <given-names>T</given-names></name><name><surname>Kay</surname> <given-names>M</given-names></name><name><surname>Laird</surname> <given-names>MR</given-names></name><name><surname>Lavidas</surname> <given-names>I</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Loveland</surname> <given-names>JE</given-names></name><name><surname>Marugán</surname> <given-names>JC</given-names></name><name><surname>Maurel</surname> <given-names>T</given-names></name><name><surname>McMahon</surname> <given-names>AC</given-names></name><name><surname>Moore</surname> <given-names>B</given-names></name><name><surname>Morales</surname> <given-names>J</given-names></name><name><surname>Mudge</surname> <given-names>JM</given-names></name><name><surname>Nuhn</surname> <given-names>M</given-names></name><name><surname>Ogeh</surname> <given-names>D</given-names></name><name><surname>Parker</surname> <given-names>A</given-names></name><name><surname>Parton</surname> <given-names>A</given-names></name><name><surname>Patricio</surname> <given-names>M</given-names></name><name><surname>Abdul Salam</surname> <given-names>AI</given-names></name><name><surname>Schmitt</surname> <given-names>BM</given-names></name><name><surname>Schuilenburg</surname> <given-names>H</given-names></name><name><surname>Sheppard</surname> <given-names>D</given-names></name><name><surname>Sparrow</surname> <given-names>H</given-names></name><name><surname>Stapleton</surname> <given-names>E</given-names></name><name><surname>Szuba</surname> <given-names>M</given-names></name><name><surname>Taylor</surname> <given-names>K</given-names></name><name><surname>Threadgold</surname> <given-names>G</given-names></name><name><surname>Thormann</surname> <given-names>A</given-names></name><name><surname>Vullo</surname> <given-names>A</given-names></name><name><surname>Walts</surname> <given-names>B</given-names></name><name><surname>Winterbottom</surname> <given-names>A</given-names></name><name><surname>Zadissa</surname> <given-names>A</given-names></name><name><surname>Chakiachvili</surname> <given-names>M</given-names></name><name><surname>Frankish</surname> <given-names>A</given-names></name><name><surname>Hunt</surname> <given-names>SE</given-names></name><name><surname>Kostadima</surname> <given-names>M</given-names></name><name><surname>Langridge</surname> <given-names>N</given-names></name><name><surname>Martin</surname> <given-names>FJ</given-names></name><name><surname>Muffato</surname> <given-names>M</given-names></name><name><surname>Perry</surname> <given-names>E</given-names></name><name><surname>Ruffier</surname> <given-names>M</given-names></name><name><surname>Staines</surname> <given-names>DM</given-names></name><name><surname>Trevanion</surname> <given-names>SJ</given-names></name><name><surname>Aken</surname> <given-names>BL</given-names></name><name><surname>Yates</surname> <given-names>AD</given-names></name><name><surname>Zerbino</surname> <given-names>DR</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ensembl 2019</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D745</fpage><lpage>D751</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1113</pub-id><pub-id pub-id-type="pmid">30407521</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahlgren</surname> <given-names>C</given-names></name><name><surname>Karlsson</surname> <given-names>A</given-names></name><name><surname>Bylund</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Measurement of respiratory burst products generated by professional phagocytes</article-title><source>Methods in Molecular Biology</source><volume>412</volume><fpage>349</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1007/978-1-59745-467-4_23</pub-id><pub-id pub-id-type="pmid">18453123</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dang</surname> <given-names>PM</given-names></name><name><surname>Fontayne</surname> <given-names>A</given-names></name><name><surname>Hakim</surname> <given-names>J</given-names></name><name><surname>El Benna</surname> <given-names>J</given-names></name><name><surname>Périanin</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Protein kinase C Zeta phosphorylates a subset of selective sites of the NADPH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst</article-title><source>The Journal of Immunology</source><volume>166</volume><fpage>1206</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.166.2.1206</pub-id><pub-id pub-id-type="pmid">11145703</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deleo</surname> <given-names>FR</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Porcella</surname> <given-names>SF</given-names></name><name><surname>Martens</surname> <given-names>CA</given-names></name><name><surname>Kobayashi</surname> <given-names>SD</given-names></name><name><surname>Porter</surname> <given-names>AR</given-names></name><name><surname>Chavda</surname> <given-names>KD</given-names></name><name><surname>Jacobs</surname> <given-names>MR</given-names></name><name><surname>Mathema</surname> <given-names>B</given-names></name><name><surname>Olsen</surname> <given-names>RJ</given-names></name><name><surname>Bonomo</surname> <given-names>RA</given-names></name><name><surname>Musser</surname> <given-names>JM</given-names></name><name><surname>Kreiswirth</surname> <given-names>BN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 <italic>Klebsiella pneumoniae</italic></article-title><source>PNAS</source><volume>111</volume><fpage>4988</fpage><lpage>4993</lpage><pub-id pub-id-type="doi">10.1073/pnas.1321364111</pub-id><pub-id pub-id-type="pmid">24639510</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dikic</surname> <given-names>I</given-names></name><name><surname>Tokiwa</surname> <given-names>G</given-names></name><name><surname>Lev</surname> <given-names>S</given-names></name><name><surname>Courtneidge</surname> <given-names>SA</given-names></name><name><surname>Schlessinger</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>A role for Pyk2 and src in linking G-protein-coupled receptors with MAP kinase activation</article-title><source>Nature</source><volume>383</volume><fpage>547</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1038/383547a0</pub-id><pub-id pub-id-type="pmid">8849729</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="report"><person-group person-group-type="author"><collab>European Centre for Disease Prevention and Control</collab></person-group><year iso-8601-date="2018">2018</year><source>Antimicrobial Resistance (EARS-Net) - Annual Epidemiological Report for 2014 Annual Epidemiological Report on Communicable Diseases in Europe</source><publisher-loc>Stockholm</publisher-loc><publisher-name>ECDC</publisher-name></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evangelista</surname> <given-names>V</given-names></name><name><surname>Pamuklar</surname> <given-names>Z</given-names></name><name><surname>Piccoli</surname> <given-names>A</given-names></name><name><surname>Manarini</surname> <given-names>S</given-names></name><name><surname>Dell'elba</surname> <given-names>G</given-names></name><name><surname>Pecce</surname> <given-names>R</given-names></name><name><surname>Martelli</surname> <given-names>N</given-names></name><name><surname>Federico</surname> <given-names>L</given-names></name><name><surname>Rojas</surname> <given-names>M</given-names></name><name><surname>Berton</surname> <given-names>G</given-names></name><name><surname>Lowell</surname> <given-names>CA</given-names></name><name><surname>Totani</surname> <given-names>L</given-names></name><name><surname>Smyth</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Src family kinases mediate neutrophil adhesion to adherent platelets</article-title><source>Blood</source><volume>109</volume><fpage>2461</fpage><lpage>2469</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-06-029082</pub-id><pub-id pub-id-type="pmid">17095622</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falagas</surname> <given-names>ME</given-names></name><name><surname>Tansarli</surname> <given-names>GS</given-names></name><name><surname>Karageorgopoulos</surname> <given-names>DE</given-names></name><name><surname>Vardakas</surname> <given-names>KZ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Deaths attributable to carbapenem-resistant <italic>Enterobacteriaceae</italic> infections</article-title><source>Emerging Infectious Diseases</source><volume>20</volume><fpage>1170</fpage><lpage>1175</lpage><pub-id pub-id-type="doi">10.3201/eid2007.121004</pub-id><pub-id pub-id-type="pmid">24959688</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname> <given-names>MF</given-names></name><name><surname>Mayer Bridwell</surname> <given-names>AE</given-names></name><name><surname>Scott</surname> <given-names>NE</given-names></name><name><surname>Vinogradov</surname> <given-names>E</given-names></name><name><surname>McKee</surname> <given-names>SR</given-names></name><name><surname>Chavez</surname> <given-names>SM</given-names></name><name><surname>Twentyman</surname> <given-names>J</given-names></name><name><surname>Stallings</surname> <given-names>CL</given-names></name><name><surname>Rosen</surname> <given-names>DA</given-names></name><name><surname>Harding</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A promising bioconjugate vaccine against hypervirulent <italic>Klebsiella pneumoniae</italic></article-title><source>PNAS</source><volume>116</volume><fpage>18655</fpage><lpage>18663</lpage><pub-id pub-id-type="doi">10.1073/pnas.1907833116</pub-id><pub-id pub-id-type="pmid">31455739</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frommhold</surname> <given-names>D</given-names></name><name><surname>Mannigel</surname> <given-names>I</given-names></name><name><surname>Schymeinsky</surname> <given-names>J</given-names></name><name><surname>Mocsai</surname> <given-names>A</given-names></name><name><surname>Poeschl</surname> <given-names>J</given-names></name><name><surname>Walzog</surname> <given-names>B</given-names></name><name><surname>Sperandio</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Spleen tyrosine kinase syk is critical for sustained leukocyte adhesion during inflammation in vivo</article-title><source>BMC Immunology</source><volume>8</volume><elocation-id>31</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2172-8-31</pub-id><pub-id pub-id-type="pmid">18045459</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fumagalli</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Baruzzi</surname> <given-names>A</given-names></name><name><surname>Lowell</surname> <given-names>CA</given-names></name><name><surname>Berton</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The src family kinases hck and fgr regulate neutrophil responses to <italic>N</italic>-formyl-methionyl-leucyl-phenylalanine</article-title><source>The Journal of Immunology</source><volume>178</volume><fpage>3874</fpage><lpage>3885</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.6.3874</pub-id><pub-id pub-id-type="pmid">17339487</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Futosi</surname> <given-names>K</given-names></name><name><surname>Fodor</surname> <given-names>S</given-names></name><name><surname>Mócsai</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Neutrophil cell surface receptors and their intracellular signal transduction pathways</article-title><source>International Immunopharmacology</source><volume>17</volume><fpage>638</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2013.06.034</pub-id><pub-id pub-id-type="pmid">23994464</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galvão</surname> <given-names>I</given-names></name><name><surname>Tavares</surname> <given-names>LP</given-names></name><name><surname>Corrêa</surname> <given-names>RO</given-names></name><name><surname>Fachi</surname> <given-names>JL</given-names></name><name><surname>Rocha</surname> <given-names>VM</given-names></name><name><surname>Rungue</surname> <given-names>M</given-names></name><name><surname>Garcia</surname> <given-names>CC</given-names></name><name><surname>Cassali</surname> <given-names>G</given-names></name><name><surname>Ferreira</surname> <given-names>CM</given-names></name><name><surname>Martins</surname> <given-names>FS</given-names></name><name><surname>Oliveira</surname> <given-names>SC</given-names></name><name><surname>Mackay</surname> <given-names>CR</given-names></name><name><surname>Teixeira</surname> <given-names>MM</given-names></name><name><surname>Vinolo</surname> <given-names>MAR</given-names></name><name><surname>Vieira</surname> <given-names>AT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The metabolic sensor GPR43 receptor plays a role in the control of <italic>Klebsiella pneumoniae</italic> Infection in the Lung</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>142</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.00142</pub-id><pub-id pub-id-type="pmid">29515566</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geering</surname> <given-names>B</given-names></name><name><surname>Gurzeler</surname> <given-names>U</given-names></name><name><surname>Federzoni</surname> <given-names>E</given-names></name><name><surname>Kaufmann</surname> <given-names>T</given-names></name><name><surname>Simon</surname> <given-names>HU</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A novel TNFR1-triggered apoptosis pathway mediated by class IA PI3Ks in neutrophils</article-title><source>Blood</source><volume>117</volume><fpage>5953</fpage><lpage>5962</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-11-322206</pub-id><pub-id pub-id-type="pmid">21478427</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geering</surname> <given-names>B</given-names></name><name><surname>Simon</surname> <given-names>HU</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Peculiarities of cell death mechanisms in neutrophils</article-title><source>Cell Death &amp; Differentiation</source><volume>18</volume><fpage>1457</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1038/cdd.2011.75</pub-id><pub-id pub-id-type="pmid">21637292</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname> <given-names>DB</given-names></name><name><surname>Robertson</surname> <given-names>CM</given-names></name><name><surname>Bautista</surname> <given-names>J</given-names></name><name><surname>Mascarenhas</surname> <given-names>F</given-names></name><name><surname>Diacovo</surname> <given-names>MJ</given-names></name><name><surname>Montgrain</surname> <given-names>V</given-names></name><name><surname>Lam</surname> <given-names>SK</given-names></name><name><surname>Cremasco</surname> <given-names>V</given-names></name><name><surname>Dunne</surname> <given-names>WM</given-names></name><name><surname>Faccio</surname> <given-names>R</given-names></name><name><surname>Coopersmith</surname> <given-names>CM</given-names></name><name><surname>Swat</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Neutrophil-mediated oxidative burst and host defense are controlled by a Vav-PLCγ2 signaling Axis in mice</article-title><source>Journal of Clinical Investigation</source><volume>117</volume><fpage>3445</fpage><lpage>3452</lpage><pub-id pub-id-type="doi">10.1172/JCI32729</pub-id><pub-id pub-id-type="pmid">17932569</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname> <given-names>ER</given-names></name><name><surname>Clark</surname> <given-names>S</given-names></name><name><surname>Crimmins</surname> <given-names>GT</given-names></name><name><surname>Mack</surname> <given-names>M</given-names></name><name><surname>Kumamoto</surname> <given-names>CA</given-names></name><name><surname>Mecsas</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fis is essential for Yersinia pseudotuberculosis virulence and protects against reactive oxygen species produced by phagocytic cells during infection</article-title><source>PLOS Pathogens</source><volume>12</volume><elocation-id>e1005898</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005898</pub-id><pub-id pub-id-type="pmid">27689357</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenberger</surname> <given-names>MJ</given-names></name><name><surname>Strieter</surname> <given-names>RM</given-names></name><name><surname>Kunkel</surname> <given-names>SL</given-names></name><name><surname>Danforth</surname> <given-names>JM</given-names></name><name><surname>Laichalk</surname> <given-names>LL</given-names></name><name><surname>McGillicuddy</surname> <given-names>DC</given-names></name><name><surname>Standiford</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia</article-title><source>The Journal of Infectious Diseases</source><volume>173</volume><fpage>159</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1093/infdis/173.1.159</pub-id><pub-id pub-id-type="pmid">8537653</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajjar</surname> <given-names>E</given-names></name><name><surname>Broemstrup</surname> <given-names>T</given-names></name><name><surname>Kantari</surname> <given-names>C</given-names></name><name><surname>Witko-Sarsat</surname> <given-names>V</given-names></name><name><surname>Reuter</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Structures of human proteinase 3 and neutrophil elastase--so similar yet so different</article-title><source>FEBS Journal</source><volume>277</volume><fpage>2238</fpage><lpage>2254</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2010.07659.x</pub-id><pub-id pub-id-type="pmid">20423453</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>H</given-names></name><name><surname>Fuortes</surname> <given-names>M</given-names></name><name><surname>Nathan</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Critical role of the carboxyl terminus of proline-rich tyrosine kinase (Pyk2) in the activation of human neutrophils by tumor necrosis factor: separation of signals for the respiratory burst and degranulation</article-title><source>The Journal of Experimental Medicine</source><volume>197</volume><fpage>63</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1084/jem.20021638</pub-id><pub-id pub-id-type="pmid">12515814</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harada</surname> <given-names>S</given-names></name><name><surname>Aoki</surname> <given-names>K</given-names></name><name><surname>Yamamoto</surname> <given-names>S</given-names></name><name><surname>Ishii</surname> <given-names>Y</given-names></name><name><surname>Sekiya</surname> <given-names>N</given-names></name><name><surname>Kurai</surname> <given-names>H</given-names></name><name><surname>Furukawa</surname> <given-names>K</given-names></name><name><surname>Doi</surname> <given-names>A</given-names></name><name><surname>Tochitani</surname> <given-names>K</given-names></name><name><surname>Kubo</surname> <given-names>K</given-names></name><name><surname>Yamaguchi</surname> <given-names>Y</given-names></name><name><surname>Narita</surname> <given-names>M</given-names></name><name><surname>Kamiyama</surname> <given-names>S</given-names></name><name><surname>Suzuki</surname> <given-names>J</given-names></name><name><surname>Fukuchi</surname> <given-names>T</given-names></name><name><surname>Gu</surname> <given-names>Y</given-names></name><name><surname>Okinaka</surname> <given-names>K</given-names></name><name><surname>Shiiki</surname> <given-names>S</given-names></name><name><surname>Hayakawa</surname> <given-names>K</given-names></name><name><surname>Tachikawa</surname> <given-names>N</given-names></name><name><surname>Kasahara</surname> <given-names>K</given-names></name><name><surname>Nakamura</surname> <given-names>T</given-names></name><name><surname>Yokota</surname> <given-names>K</given-names></name><name><surname>Komatsu</surname> <given-names>M</given-names></name><name><surname>Takamiya</surname> <given-names>M</given-names></name><name><surname>Tateda</surname> <given-names>K</given-names></name><name><surname>Doi</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Clinical and molecular characteristics of <italic>Klebsiella pneumoniae</italic> isolates causing bloodstream infections in japan: occurrence of hypervirulent infections in health care</article-title><source>Journal of Clinical Microbiology</source><volume>57</volume><elocation-id>e01206-19</elocation-id><pub-id pub-id-type="doi">10.1128/JCM.01206-19</pub-id><pub-id pub-id-type="pmid">31434721</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirche</surname> <given-names>TO</given-names></name><name><surname>Gaut</surname> <given-names>JP</given-names></name><name><surname>Heinecke</surname> <given-names>JW</given-names></name><name><surname>Belaaouaj</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Myeloperoxidase plays critical roles in killing <italic>Klebsiella pneumoniae</italic> and inactivating neutrophil elastase: effects on host defense</article-title><source>The Journal of Immunology</source><volume>174</volume><fpage>1557</fpage><lpage>1565</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.174.3.1557</pub-id><pub-id pub-id-type="pmid">15661916</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname> <given-names>MH</given-names></name><name><surname>Griffiths</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The dual role of reactive oxygen species in autoimmune and inflammatory diseases: evidence from preclinical models</article-title><source>Free Radical Biology and Medicine</source><volume>125</volume><fpage>62</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.03.016</pub-id><pub-id pub-id-type="pmid">29550327</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname> <given-names>KE</given-names></name><name><surname>Wertheim</surname> <given-names>H</given-names></name><name><surname>Zadoks</surname> <given-names>RN</given-names></name><name><surname>Baker</surname> <given-names>S</given-names></name><name><surname>Whitehouse</surname> <given-names>CA</given-names></name><name><surname>Dance</surname> <given-names>D</given-names></name><name><surname>Jenney</surname> <given-names>A</given-names></name><name><surname>Connor</surname> <given-names>TR</given-names></name><name><surname>Hsu</surname> <given-names>LY</given-names></name><name><surname>Severin</surname> <given-names>J</given-names></name><name><surname>Brisse</surname> <given-names>S</given-names></name><name><surname>Cao</surname> <given-names>H</given-names></name><name><surname>Wilksch</surname> <given-names>J</given-names></name><name><surname>Gorrie</surname> <given-names>C</given-names></name><name><surname>Schultz</surname> <given-names>MB</given-names></name><name><surname>Edwards</surname> <given-names>DJ</given-names></name><name><surname>Nguyen</surname> <given-names>KV</given-names></name><name><surname>Nguyen</surname> <given-names>TV</given-names></name><name><surname>Dao</surname> <given-names>TT</given-names></name><name><surname>Mensink</surname> <given-names>M</given-names></name><name><surname>Minh</surname> <given-names>VL</given-names></name><name><surname>Nhu</surname> <given-names>NT</given-names></name><name><surname>Schultsz</surname> <given-names>C</given-names></name><name><surname>Kuntaman</surname> <given-names>K</given-names></name><name><surname>Newton</surname> <given-names>PN</given-names></name><name><surname>Moore</surname> <given-names>CE</given-names></name><name><surname>Strugnell</surname> <given-names>RA</given-names></name><name><surname>Thomson</surname> <given-names>NR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in <italic>Klebsiella pneumoniae</italic>, an urgent threat to public health</article-title><source>PNAS</source><volume>112</volume><fpage>E3574</fpage><lpage>E3581</lpage><pub-id pub-id-type="doi">10.1073/pnas.1501049112</pub-id><pub-id pub-id-type="pmid">26100894</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivin</surname> <given-names>M</given-names></name><name><surname>Dumigan</surname> <given-names>A</given-names></name><name><surname>de Vasconcelos</surname> <given-names>FN</given-names></name><name><surname>Ebner</surname> <given-names>F</given-names></name><name><surname>Borroni</surname> <given-names>M</given-names></name><name><surname>Kavirayani</surname> <given-names>A</given-names></name><name><surname>Przybyszewska</surname> <given-names>KN</given-names></name><name><surname>Ingram</surname> <given-names>RJ</given-names></name><name><surname>Lienenklaus</surname> <given-names>S</given-names></name><name><surname>Kalinke</surname> <given-names>U</given-names></name><name><surname>Stoiber</surname> <given-names>D</given-names></name><name><surname>Bengoechea</surname> <given-names>JA</given-names></name><name><surname>Kovarik</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Natural killer cell-intrinsic type I IFN signaling controls Klebsiella pneumoniae growth during lung infection</article-title><source>PLOS Pathogens</source><volume>13</volume><elocation-id>e1006696</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006696</pub-id><pub-id pub-id-type="pmid">29112952</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jostins</surname> <given-names>L</given-names></name><name><surname>Ripke</surname> <given-names>S</given-names></name><name><surname>Weersma</surname> <given-names>RK</given-names></name><name><surname>Duerr</surname> <given-names>RH</given-names></name><name><surname>McGovern</surname> <given-names>DP</given-names></name><name><surname>Hui</surname> <given-names>KY</given-names></name><name><surname>Lee</surname> <given-names>JC</given-names></name><name><surname>Schumm</surname> <given-names>LP</given-names></name><name><surname>Sharma</surname> <given-names>Y</given-names></name><name><surname>Anderson</surname> <given-names>CA</given-names></name><name><surname>Essers</surname> <given-names>J</given-names></name><name><surname>Mitrovic</surname> <given-names>M</given-names></name><name><surname>Ning</surname> <given-names>K</given-names></name><name><surname>Cleynen</surname> <given-names>I</given-names></name><name><surname>Theatre</surname> <given-names>E</given-names></name><name><surname>Spain</surname> <given-names>SL</given-names></name><name><surname>Raychaudhuri</surname> <given-names>S</given-names></name><name><surname>Goyette</surname> <given-names>P</given-names></name><name><surname>Wei</surname> <given-names>Z</given-names></name><name><surname>Abraham</surname> <given-names>C</given-names></name><name><surname>Achkar</surname> <given-names>JP</given-names></name><name><surname>Ahmad</surname> <given-names>T</given-names></name><name><surname>Amininejad</surname> <given-names>L</given-names></name><name><surname>Ananthakrishnan</surname> <given-names>AN</given-names></name><name><surname>Andersen</surname> <given-names>V</given-names></name><name><surname>Andrews</surname> <given-names>JM</given-names></name><name><surname>Baidoo</surname> <given-names>L</given-names></name><name><surname>Balschun</surname> <given-names>T</given-names></name><name><surname>Bampton</surname> <given-names>PA</given-names></name><name><surname>Bitton</surname> <given-names>A</given-names></name><name><surname>Boucher</surname> <given-names>G</given-names></name><name><surname>Brand</surname> <given-names>S</given-names></name><name><surname>Büning</surname> <given-names>C</given-names></name><name><surname>Cohain</surname> <given-names>A</given-names></name><name><surname>Cichon</surname> <given-names>S</given-names></name><name><surname>D'Amato</surname> <given-names>M</given-names></name><name><surname>De Jong</surname> <given-names>D</given-names></name><name><surname>Devaney</surname> <given-names>KL</given-names></name><name><surname>Dubinsky</surname> <given-names>M</given-names></name><name><surname>Edwards</surname> <given-names>C</given-names></name><name><surname>Ellinghaus</surname> <given-names>D</given-names></name><name><surname>Ferguson</surname> <given-names>LR</given-names></name><name><surname>Franchimont</surname> <given-names>D</given-names></name><name><surname>Fransen</surname> <given-names>K</given-names></name><name><surname>Gearry</surname> <given-names>R</given-names></name><name><surname>Georges</surname> <given-names>M</given-names></name><name><surname>Gieger</surname> <given-names>C</given-names></name><name><surname>Glas</surname> <given-names>J</given-names></name><name><surname>Haritunians</surname> <given-names>T</given-names></name><name><surname>Hart</surname> <given-names>A</given-names></name><name><surname>Hawkey</surname> <given-names>C</given-names></name><name><surname>Hedl</surname> <given-names>M</given-names></name><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Karlsen</surname> <given-names>TH</given-names></name><name><surname>Kupcinskas</surname> <given-names>L</given-names></name><name><surname>Kugathasan</surname> <given-names>S</given-names></name><name><surname>Latiano</surname> <given-names>A</given-names></name><name><surname>Laukens</surname> <given-names>D</given-names></name><name><surname>Lawrance</surname> <given-names>IC</given-names></name><name><surname>Lees</surname> <given-names>CW</given-names></name><name><surname>Louis</surname> <given-names>E</given-names></name><name><surname>Mahy</surname> <given-names>G</given-names></name><name><surname>Mansfield</surname> <given-names>J</given-names></name><name><surname>Morgan</surname> <given-names>AR</given-names></name><name><surname>Mowat</surname> <given-names>C</given-names></name><name><surname>Newman</surname> <given-names>W</given-names></name><name><surname>Palmieri</surname> <given-names>O</given-names></name><name><surname>Ponsioen</surname> <given-names>CY</given-names></name><name><surname>Potocnik</surname> <given-names>U</given-names></name><name><surname>Prescott</surname> <given-names>NJ</given-names></name><name><surname>Regueiro</surname> <given-names>M</given-names></name><name><surname>Rotter</surname> <given-names>JI</given-names></name><name><surname>Russell</surname> <given-names>RK</given-names></name><name><surname>Sanderson</surname> <given-names>JD</given-names></name><name><surname>Sans</surname> <given-names>M</given-names></name><name><surname>Satsangi</surname> <given-names>J</given-names></name><name><surname>Schreiber</surname> <given-names>S</given-names></name><name><surname>Simms</surname> <given-names>LA</given-names></name><name><surname>Sventoraityte</surname> <given-names>J</given-names></name><name><surname>Targan</surname> <given-names>SR</given-names></name><name><surname>Taylor</surname> <given-names>KD</given-names></name><name><surname>Tremelling</surname> <given-names>M</given-names></name><name><surname>Verspaget</surname> <given-names>HW</given-names></name><name><surname>De Vos</surname> <given-names>M</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>Wilson</surname> <given-names>DC</given-names></name><name><surname>Winkelmann</surname> <given-names>J</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Zeissig</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Zhang</surname> <given-names>CK</given-names></name><name><surname>Zhao</surname> <given-names>H</given-names></name><name><surname>Silverberg</surname> <given-names>MS</given-names></name><name><surname>Annese</surname> <given-names>V</given-names></name><name><surname>Hakonarson</surname> <given-names>H</given-names></name><name><surname>Brant</surname> <given-names>SR</given-names></name><name><surname>Radford-Smith</surname> <given-names>G</given-names></name><name><surname>Mathew</surname> <given-names>CG</given-names></name><name><surname>Rioux</surname> <given-names>JD</given-names></name><name><surname>Schadt</surname> <given-names>EE</given-names></name><name><surname>Daly</surname> <given-names>MJ</given-names></name><name><surname>Franke</surname> <given-names>A</given-names></name><name><surname>Parkes</surname> <given-names>M</given-names></name><name><surname>Vermeire</surname> <given-names>S</given-names></name><name><surname>Barrett</surname> <given-names>JC</given-names></name><name><surname>Cho</surname> <given-names>JH</given-names></name><collab>International IBD Genetics Consortium (IIBDGC)</collab></person-group><year iso-8601-date="2012">2012</year><article-title>Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease</article-title><source>Nature</source><volume>491</volume><fpage>119</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1038/nature11582</pub-id><pub-id pub-id-type="pmid">23128233</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamen</surname> <given-names>LA</given-names></name><name><surname>Schlessinger</surname> <given-names>J</given-names></name><name><surname>Lowell</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Pyk2 is required for neutrophil degranulation and host defense responses to bacterial infection</article-title><source>The Journal of Immunology</source><volume>186</volume><fpage>1656</fpage><lpage>1665</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1002093</pub-id><pub-id pub-id-type="pmid">21187437</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname> <given-names>SD</given-names></name><name><surname>Porter</surname> <given-names>AR</given-names></name><name><surname>Dorward</surname> <given-names>DW</given-names></name><name><surname>Brinkworth</surname> <given-names>AJ</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Kreiswirth</surname> <given-names>BN</given-names></name><name><surname>DeLeo</surname> <given-names>FR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Phagocytosis and killing of Carbapenem-Resistant ST258 <italic>Klebsiella pneumoniae</italic> by Human Neutrophils</article-title><source>Journal of Infectious Diseases</source><volume>213</volume><fpage>1615</fpage><lpage>1622</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiw001</pub-id><pub-id pub-id-type="pmid">26768252</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouroku</surname> <given-names>Y</given-names></name><name><surname>Soyama</surname> <given-names>A</given-names></name><name><surname>Fujita</surname> <given-names>E</given-names></name><name><surname>Urase</surname> <given-names>K</given-names></name><name><surname>Tsukahara</surname> <given-names>T</given-names></name><name><surname>Momoi</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>RA70 is a src kinase-associated protein expressed ubiquitously</article-title><source>Biochemical and Biophysical Research Communications</source><volume>252</volume><fpage>738</fpage><lpage>742</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1998.9637</pub-id><pub-id pub-id-type="pmid">9837776</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovács</surname> <given-names>M</given-names></name><name><surname>Németh</surname> <given-names>T</given-names></name><name><surname>Jakus</surname> <given-names>Z</given-names></name><name><surname>Sitaru</surname> <given-names>C</given-names></name><name><surname>Simon</surname> <given-names>E</given-names></name><name><surname>Futosi</surname> <given-names>K</given-names></name><name><surname>Botz</surname> <given-names>B</given-names></name><name><surname>Helyes</surname> <given-names>Z</given-names></name><name><surname>Lowell</surname> <given-names>CA</given-names></name><name><surname>Mócsai</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The src family kinases hck, fgr, and lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment</article-title><source>Journal of Experimental Medicine</source><volume>211</volume><fpage>1993</fpage><lpage>2011</lpage><pub-id pub-id-type="doi">10.1084/jem.20132496</pub-id><pub-id pub-id-type="pmid">25225462</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname> <given-names>MMC</given-names></name><name><surname>Wyres</surname> <given-names>KL</given-names></name><name><surname>Duchêne</surname> <given-names>S</given-names></name><name><surname>Wick</surname> <given-names>RR</given-names></name><name><surname>Judd</surname> <given-names>LM</given-names></name><name><surname>Gan</surname> <given-names>YH</given-names></name><name><surname>Hoh</surname> <given-names>CH</given-names></name><name><surname>Archuleta</surname> <given-names>S</given-names></name><name><surname>Molton</surname> <given-names>JS</given-names></name><name><surname>Kalimuddin</surname> <given-names>S</given-names></name><name><surname>Koh</surname> <given-names>TH</given-names></name><name><surname>Passet</surname> <given-names>V</given-names></name><name><surname>Brisse</surname> <given-names>S</given-names></name><name><surname>Holt</surname> <given-names>KE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global dissemination</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>2703</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-05114-7</pub-id><pub-id pub-id-type="pmid">30006589</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawlor</surname> <given-names>MS</given-names></name><name><surname>Hsu</surname> <given-names>J</given-names></name><name><surname>Rick</surname> <given-names>PD</given-names></name><name><surname>Miller</surname> <given-names>VL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Identification of <italic>Klebsiella pneumoniae</italic> virulence determinants using an intranasal infection model</article-title><source>Molecular Microbiology</source><volume>58</volume><fpage>1054</fpage><lpage>1073</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04918.x</pub-id><pub-id pub-id-type="pmid">16262790</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Kang</surname> <given-names>H</given-names></name><name><surname>Raab</surname> <given-names>M</given-names></name><name><surname>da Silva</surname> <given-names>AJ</given-names></name><name><surname>Kraeft</surname> <given-names>SK</given-names></name><name><surname>Rudd</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>FYB (FYN binding protein) serves as a binding partner for lymphoid protein and FYN kinase substrate SKAP55 and a SKAP55-related protein in T cells</article-title><source>PNAS</source><volume>95</volume><fpage>8779</fpage><lpage>8784</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.15.8779</pub-id><pub-id pub-id-type="pmid">9671755</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Löfgren</surname> <given-names>R</given-names></name><name><surname>Serrander</surname> <given-names>L</given-names></name><name><surname>Forsberg</surname> <given-names>M</given-names></name><name><surname>Wilsson</surname> <given-names>Åsa</given-names></name><name><surname>Wasteson</surname> <given-names>Åke</given-names></name><name><surname>Stendahl</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>CR3, fcγriia and fcγriiib induce activation of the respiratory burst in human neutrophils: the role of intracellular Ca2+, phospholipase D and tyrosine phosphorylation</article-title><source>Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research</source><volume>1452</volume><fpage>46</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/S0167-4889(99)00112-3</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowell</surname> <given-names>CA</given-names></name><name><surname>Fumagalli</surname> <given-names>L</given-names></name><name><surname>Berton</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Deficiency of src family kinases p59/61hck and p58c-fgr results in defective adhesion-dependent neutrophil functions</article-title><source>The Journal of Cell Biology</source><volume>133</volume><fpage>895</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1083/jcb.133.4.895</pub-id><pub-id pub-id-type="pmid">8666673</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowell</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Src-family and syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>3</volume><elocation-id>a002352</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a002352</pub-id><pub-id pub-id-type="pmid">21068150</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mack</surname> <given-names>M</given-names></name><name><surname>Cihak</surname> <given-names>J</given-names></name><name><surname>Simonis</surname> <given-names>C</given-names></name><name><surname>Luckow</surname> <given-names>B</given-names></name><name><surname>Proudfoot</surname> <given-names>AE</given-names></name><name><surname>Plachý</surname> <given-names>J</given-names></name><name><surname>Brühl</surname> <given-names>H</given-names></name><name><surname>Frink</surname> <given-names>M</given-names></name><name><surname>Anders</surname> <given-names>HJ</given-names></name><name><surname>Vielhauer</surname> <given-names>V</given-names></name><name><surname>Pfirstinger</surname> <given-names>J</given-names></name><name><surname>Stangassinger</surname> <given-names>M</given-names></name><name><surname>Schlöndorff</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice</article-title><source>The Journal of Immunology</source><volume>166</volume><fpage>4697</fpage><lpage>4704</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.166.7.4697</pub-id><pub-id pub-id-type="pmid">11254730</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>March</surname> <given-names>C</given-names></name><name><surname>Cano</surname> <given-names>V</given-names></name><name><surname>Moranta</surname> <given-names>D</given-names></name><name><surname>Llobet</surname> <given-names>E</given-names></name><name><surname>Pérez-Gutiérrez</surname> <given-names>C</given-names></name><name><surname>Tomás</surname> <given-names>JM</given-names></name><name><surname>Suárez</surname> <given-names>T</given-names></name><name><surname>Garmendia</surname> <given-names>J</given-names></name><name><surname>Bengoechea</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Role of bacterial surface structures on the interaction of Klebsiella pneumoniae with phagocytes</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e56847</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0056847</pub-id><pub-id pub-id-type="pmid">23457627</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marie-Cardine</surname> <given-names>A</given-names></name><name><surname>Verhagen</surname> <given-names>AM</given-names></name><name><surname>Eckerskorn</surname> <given-names>C</given-names></name><name><surname>Schraven</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>SKAP-HOM, a novel adaptor protein homologous to the FYN-associated protein SKAP55</article-title><source>FEBS Letters</source><volume>435</volume><fpage>55</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(98)01040-0</pub-id><pub-id pub-id-type="pmid">9755858</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ménasché</surname> <given-names>G</given-names></name><name><surname>Kliche</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>EJ</given-names></name><name><surname>Stradal</surname> <given-names>TE</given-names></name><name><surname>Schraven</surname> <given-names>B</given-names></name><name><surname>Koretzky</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>RIAM links the ADAP/SKAP-55 signaling module to Rap1, facilitating T-Cell-Receptor-Mediated integrin activation</article-title><source>Molecular and Cellular Biology</source><volume>27</volume><fpage>4070</fpage><lpage>4081</lpage><pub-id pub-id-type="doi">10.1128/MCB.02011-06</pub-id><pub-id pub-id-type="pmid">17403904</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mestas</surname> <given-names>J</given-names></name><name><surname>Hughes</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Of mice and not men: differences between mouse and human immunology</article-title><source>The Journal of Immunology</source><volume>172</volume><fpage>2731</fpage><lpage>2738</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.172.5.2731</pub-id><pub-id pub-id-type="pmid">14978070</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Micozzi</surname> <given-names>A</given-names></name><name><surname>Gentile</surname> <given-names>G</given-names></name><name><surname>Minotti</surname> <given-names>C</given-names></name><name><surname>Cartoni</surname> <given-names>C</given-names></name><name><surname>Capria</surname> <given-names>S</given-names></name><name><surname>Ballarò</surname> <given-names>D</given-names></name><name><surname>Santilli</surname> <given-names>S</given-names></name><name><surname>Pacetti</surname> <given-names>E</given-names></name><name><surname>Grammatico</surname> <given-names>S</given-names></name><name><surname>Bucaneve</surname> <given-names>G</given-names></name><name><surname>Foà</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias</article-title><source>BMC Infectious Diseases</source><volume>17</volume><elocation-id>203</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-017-2297-9</pub-id><pub-id pub-id-type="pmid">28283020</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizgerd</surname> <given-names>JP</given-names></name><name><surname>Skerrett</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Animal models of human pneumonia</article-title><source>American Journal of Physiology-Lung Cellular and Molecular Physiology</source><volume>294</volume><fpage>L387</fpage><lpage>L398</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00330.2007</pub-id><pub-id pub-id-type="pmid">18162603</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mócsai</surname> <given-names>A</given-names></name><name><surname>Ligeti</surname> <given-names>E</given-names></name><name><surname>Lowell</surname> <given-names>CA</given-names></name><name><surname>Berton</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Adhesion-dependent degranulation of neutrophils requires the src family kinases fgr and hck</article-title><source>Journal of Immunology</source><volume>162</volume><fpage>1120</fpage><lpage>1126</lpage><pub-id pub-id-type="pmid">9916742</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mócsai</surname> <given-names>A</given-names></name><name><surname>Zhou</surname> <given-names>M</given-names></name><name><surname>Meng</surname> <given-names>F</given-names></name><name><surname>Tybulewicz</surname> <given-names>VL</given-names></name><name><surname>Lowell</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Syk is required for integrin signaling in neutrophils</article-title><source>Immunity</source><volume>16</volume><fpage>547</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(02)00303-5</pub-id><pub-id pub-id-type="pmid">11970878</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mócsai</surname> <given-names>A</given-names></name><name><surname>Ruland</surname> <given-names>J</given-names></name><name><surname>Tybulewicz</surname> <given-names>VL</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The SYK tyrosine kinase: a crucial player in diverse biological functions</article-title><source>Nature Reviews Immunology</source><volume>10</volume><fpage>387</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1038/nri2765</pub-id><pub-id pub-id-type="pmid">20467426</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mócsai</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Diverse novel functions of neutrophils in immunity, inflammation, and beyond</article-title><source>The Journal of Experimental Medicine</source><volume>210</volume><fpage>1283</fpage><lpage>1299</lpage><pub-id pub-id-type="doi">10.1084/jem.20122220</pub-id><pub-id pub-id-type="pmid">23825232</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moog-Lutz</surname> <given-names>C</given-names></name><name><surname>Peterson</surname> <given-names>EJ</given-names></name><name><surname>Lutz</surname> <given-names>PG</given-names></name><name><surname>Eliason</surname> <given-names>S</given-names></name><name><surname>Cavé-Riant</surname> <given-names>F</given-names></name><name><surname>Singer</surname> <given-names>A</given-names></name><name><surname>Di Gioia</surname> <given-names>Y</given-names></name><name><surname>Dmowski</surname> <given-names>S</given-names></name><name><surname>Kamens</surname> <given-names>J</given-names></name><name><surname>Cayre</surname> <given-names>YE</given-names></name><name><surname>Koretzky</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells</article-title><source>Journal of Biological Chemistry</source><volume>276</volume><fpage>22375</fpage><lpage>22381</lpage><pub-id pub-id-type="doi">10.1074/jbc.M011683200</pub-id><pub-id pub-id-type="pmid">11301322</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moroco</surname> <given-names>JA</given-names></name><name><surname>Craigo</surname> <given-names>JK</given-names></name><name><surname>Iacob</surname> <given-names>RE</given-names></name><name><surname>Wales</surname> <given-names>TE</given-names></name><name><surname>Engen</surname> <given-names>JR</given-names></name><name><surname>Smithgall</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Differential sensitivity of Src-family kinases to activation by SH3 domain displacement</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e105629</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0105629</pub-id><pub-id pub-id-type="pmid">25144189</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>GT</given-names></name><name><surname>Green</surname> <given-names>ER</given-names></name><name><surname>Mecsas</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Neutrophils to the ROScue: mechanisms of NADPH oxidase activation and bacterial resistance</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>7</volume><elocation-id>373</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2017.00373</pub-id><pub-id pub-id-type="pmid">28890882</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ophir</surname> <given-names>MJ</given-names></name><name><surname>Liu</surname> <given-names>BC</given-names></name><name><surname>Bunnell</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The N terminus of SKAP55 enables T cell adhesion to TCR and integrin ligands via distinct mechanisms</article-title><source>The Journal of Cell Biology</source><volume>203</volume><fpage>1021</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1083/jcb.201305088</pub-id><pub-id pub-id-type="pmid">24368808</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paczosa</surname> <given-names>MK</given-names></name><name><surname>Silver</surname> <given-names>RJ</given-names></name><name><surname>McCabe</surname> <given-names>AL</given-names></name><name><surname>Tai</surname> <given-names>AK</given-names></name><name><surname>McLeish</surname> <given-names>CH</given-names></name><name><surname>Lazinski</surname> <given-names>DW</given-names></name><name><surname>Mecsas</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transposon mutagenesis screen of <italic>Klebsiella pneumoniae</italic> identifies multiple genes important for resisting antimicrobial activities of neutrophils in mice</article-title><source>Infection and Immunity</source><volume>88</volume><elocation-id>e00034-20</elocation-id><pub-id pub-id-type="doi">10.1128/IAI.00034-20</pub-id><pub-id pub-id-type="pmid">31988174</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paczosa</surname> <given-names>MK</given-names></name><name><surname>Mecsas</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Klebsiella pneumoniae: going on the offense with a strong defense</article-title><source>Microbiology and Molecular Biology Reviews</source><volume>80</volume><fpage>629</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00078-15</pub-id><pub-id pub-id-type="pmid">27307579</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papayannopoulos</surname> <given-names>V</given-names></name><name><surname>Metzler</surname> <given-names>KD</given-names></name><name><surname>Hakkim</surname> <given-names>A</given-names></name><name><surname>Zychlinsky</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps</article-title><source>The Journal of Cell Biology</source><volume>191</volume><fpage>677</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1083/jcb.201006052</pub-id><pub-id pub-id-type="pmid">20974816</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelletier</surname> <given-names>MG</given-names></name><name><surname>Szymczak</surname> <given-names>K</given-names></name><name><surname>Barbeau</surname> <given-names>AM</given-names></name><name><surname>Prata</surname> <given-names>GN</given-names></name><name><surname>O'Fallon</surname> <given-names>KS</given-names></name><name><surname>Gaines</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Characterization of neutrophils and macrophages from ex vivo-cultured murine bone marrow for morphologic maturation and functional responses by imaging flow cytometry</article-title><source>Methods</source><volume>112</volume><fpage>124</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2016.09.005</pub-id><pub-id pub-id-type="pmid">27663441</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterman</surname> <given-names>EE</given-names></name><name><surname>Taormina</surname> <given-names>P</given-names></name><name><surname>Harvey</surname> <given-names>M</given-names></name><name><surname>Young</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Gö 6983 exerts cardioprotective effects in myocardial ischemia/reperfusion</article-title><source>Journal of Cardiovascular Pharmacology</source><volume>43</volume><fpage>645</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1097/00005344-200405000-00006</pub-id><pub-id pub-id-type="pmid">15071351</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prezzo</surname> <given-names>A</given-names></name><name><surname>Cavaliere</surname> <given-names>FM</given-names></name><name><surname>Bilotta</surname> <given-names>C</given-names></name><name><surname>Pentimalli</surname> <given-names>TM</given-names></name><name><surname>Iacobini</surname> <given-names>M</given-names></name><name><surname>Cesini</surname> <given-names>L</given-names></name><name><surname>Foà</surname> <given-names>R</given-names></name><name><surname>Mauro</surname> <given-names>FR</given-names></name><name><surname>Quinti</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ibrutinib-based therapy impaired neutrophils microbicidal activity in patients with chronic lymphocytic leukemia during the early phases of treatment</article-title><source>Leukemia Research</source><volume>87</volume><elocation-id>106233</elocation-id><pub-id pub-id-type="doi">10.1016/j.leukres.2019.106233</pub-id><pub-id pub-id-type="pmid">31639635</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raab</surname> <given-names>M</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Kohler</surname> <given-names>K</given-names></name><name><surname>Smith</surname> <given-names>X</given-names></name><name><surname>Strebhardt</surname> <given-names>K</given-names></name><name><surname>Rudd</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>LFA-1 activates focal adhesion kinases FAK1/PYK2 to generate LAT-GRB2-SKAP1 complexes that terminate T-cell conjugate formation</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>16001</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms16001</pub-id><pub-id pub-id-type="pmid">28699640</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raad</surname> <given-names>H</given-names></name><name><surname>Paclet</surname> <given-names>MH</given-names></name><name><surname>Boussetta</surname> <given-names>T</given-names></name><name><surname>Kroviarski</surname> <given-names>Y</given-names></name><name><surname>Morel</surname> <given-names>F</given-names></name><name><surname>Quinn</surname> <given-names>MT</given-names></name><name><surname>Gougerot-Pocidalo</surname> <given-names>MA</given-names></name><name><surname>Dang</surname> <given-names>PM</given-names></name><name><surname>El-Benna</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Regulation of the phagocyte NADPH oxidase activity: phosphorylation of gp91phox/NOX2 by protein kinase C enhances its diaphorase activity and binding to Rac2, p67phox, and p47phox</article-title><source>The FASEB Journal</source><volume>23</volume><fpage>1011</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1096/fj.08-114553</pub-id><pub-id pub-id-type="pmid">19028840</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regueiro</surname> <given-names>V</given-names></name><name><surname>Campos</surname> <given-names>MA</given-names></name><name><surname>Pons</surname> <given-names>J</given-names></name><name><surname>Albertí</surname> <given-names>S</given-names></name><name><surname>Bengoechea</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The uptake of a Klebsiella pneumoniae capsule polysaccharide mutant triggers an inflammatory response by human airway epithelial cells</article-title><source>Microbiology</source><volume>152</volume><fpage>555</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1099/mic.0.28285-0</pub-id><pub-id pub-id-type="pmid">16436443</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolán</surname> <given-names>HG</given-names></name><name><surname>Durand</surname> <given-names>EA</given-names></name><name><surname>Mecsas</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Identifying Yersinia YopH-targeted signal transduction pathways that impair neutrophil responses during in vivo murine infection</article-title><source>Cell Host &amp; Microbe</source><volume>14</volume><fpage>306</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.08.013</pub-id><pub-id pub-id-type="pmid">24034616</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schymeinsky</surname> <given-names>J</given-names></name><name><surname>Sindrilaru</surname> <given-names>A</given-names></name><name><surname>Frommhold</surname> <given-names>D</given-names></name><name><surname>Sperandio</surname> <given-names>M</given-names></name><name><surname>Gerstl</surname> <given-names>R</given-names></name><name><surname>Then</surname> <given-names>C</given-names></name><name><surname>Mócsai</surname> <given-names>A</given-names></name><name><surname>Scharffetter-Kochanek</surname> <given-names>K</given-names></name><name><surname>Walzog</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The vav binding site of the non-receptor tyrosine kinase syk at tyr 348 is critical for β2 integrin (CD11/CD18)-mediated neutrophil migration</article-title><source>Blood</source><volume>108</volume><fpage>3919</fpage><lpage>3927</lpage><pub-id pub-id-type="doi">10.1182/blood-2005-12-030387</pub-id><pub-id pub-id-type="pmid">16882714</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>A</given-names></name><name><surname>Steichen</surname> <given-names>AL</given-names></name><name><surname>Jondle</surname> <given-names>CN</given-names></name><name><surname>Mishra</surname> <given-names>BB</given-names></name><name><surname>Sharma</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Protective role of mincle in bacterial pneumonia by regulation of neutrophil mediated phagocytosis and extracellular trap formation</article-title><source>Journal of Infectious Diseases</source><volume>209</volume><fpage>1837</fpage><lpage>1846</lpage><pub-id pub-id-type="doi">10.1093/infdis/jit820</pub-id><pub-id pub-id-type="pmid">24353272</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>A</given-names></name><name><surname>Simonson</surname> <given-names>TJ</given-names></name><name><surname>Jondle</surname> <given-names>CN</given-names></name><name><surname>Mishra</surname> <given-names>BB</given-names></name><name><surname>Sharma</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mincle-Mediated neutrophil extracellular trap formation by regulation of autophagy</article-title><source>The Journal of Infectious Diseases</source><volume>215</volume><fpage>1040</fpage><lpage>1048</lpage><pub-id pub-id-type="doi">10.1093/infdis/jix072</pub-id><pub-id pub-id-type="pmid">28186242</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheshachalam</surname> <given-names>A</given-names></name><name><surname>Srivastava</surname> <given-names>N</given-names></name><name><surname>Mitchell</surname> <given-names>T</given-names></name><name><surname>Lacy</surname> <given-names>P</given-names></name><name><surname>Eitzen</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Granule protein processing and regulated secretion in neutrophils</article-title><source>Frontiers in Immunology</source><volume>5</volume><elocation-id>448</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2014.00448</pub-id><pub-id pub-id-type="pmid">25285096</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimamura</surname> <given-names>S</given-names></name><name><surname>Sasaki</surname> <given-names>K</given-names></name><name><surname>Tanaka</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The src substrate SKAP2 regulates actin assembly by interacting with WAVE2 and cortactin proteins</article-title><source>Journal of Biological Chemistry</source><volume>288</volume><fpage>1171</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.386722</pub-id><pub-id pub-id-type="pmid">23161539</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silver</surname> <given-names>RJ</given-names></name><name><surname>Paczosa</surname> <given-names>MK</given-names></name><name><surname>McCabe</surname> <given-names>AL</given-names></name><name><surname>Balada-Llasat</surname> <given-names>J-M</given-names></name><name><surname>Baleja</surname> <given-names>JD</given-names></name><name><surname>Mecsas</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Amino acid biosynthetic pathways are required for <italic>klebsiella pneumoniae</italic> growth in immunocompromised lungs and are druggable targets during infection</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>63</volume><elocation-id>e02674-18</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.02674-18</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>N</given-names></name><name><surname>Oh</surname> <given-names>KS</given-names></name><name><surname>Dutta</surname> <given-names>B</given-names></name><name><surname>Vayttaden</surname> <given-names>SJ</given-names></name><name><surname>Lin</surname> <given-names>B</given-names></name><name><surname>Ebert</surname> <given-names>TS</given-names></name><name><surname>De Nardo</surname> <given-names>D</given-names></name><name><surname>Davis</surname> <given-names>J</given-names></name><name><surname>Bagirzadeh</surname> <given-names>R</given-names></name><name><surname>Lounsbury</surname> <given-names>NW</given-names></name><name><surname>Pasare</surname> <given-names>C</given-names></name><name><surname>Latz</surname> <given-names>E</given-names></name><name><surname>Hornung</surname> <given-names>V</given-names></name><name><surname>Fraser</surname> <given-names>ID</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use</article-title><source>Science Signaling</source><volume>9</volume><elocation-id>ra3</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aab2191</pub-id><pub-id pub-id-type="pmid">26732763</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname> <given-names>KD</given-names></name><name><surname>Tang</surname> <given-names>Y</given-names></name><name><surname>Ceccarelli</surname> <given-names>DF</given-names></name><name><surname>Poy</surname> <given-names>F</given-names></name><name><surname>Sliwa</surname> <given-names>JP</given-names></name><name><surname>Neel</surname> <given-names>BG</given-names></name><name><surname>Eck</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The Skap-hom dimerization and PH domains comprise a 3'-phosphoinositide-gated molecular switch</article-title><source>Molecular Cell</source><volume>32</volume><fpage>564</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2008.09.022</pub-id><pub-id pub-id-type="pmid">19026786</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname> <given-names>M</given-names></name><name><surname>Shimamura</surname> <given-names>S</given-names></name><name><surname>Kuriyama</surname> <given-names>S</given-names></name><name><surname>Maeda</surname> <given-names>D</given-names></name><name><surname>Goto</surname> <given-names>A</given-names></name><name><surname>Aiba</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SKAP2 promotes podosome formation to facilitate Tumor-Associated macrophage infiltration and metastatic progression</article-title><source>Cancer Research</source><volume>76</volume><fpage>358</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-15-1879</pub-id><pub-id pub-id-type="pmid">26577701</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname> <given-names>Y</given-names></name><name><surname>Miao</surname> <given-names>J</given-names></name><name><surname>Shen</surname> <given-names>X</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Ren</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Huang</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The modulation of MiR-155 and MiR-23a manipulates Klebsiella pneumoniae adhesion on human pulmonary epithelial cells via integrin α5β1 signaling</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>31918</elocation-id><pub-id pub-id-type="doi">10.1038/srep31918</pub-id><pub-id pub-id-type="pmid">27534887</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timms</surname> <given-names>JF</given-names></name><name><surname>Swanson</surname> <given-names>KD</given-names></name><name><surname>Marie-Cardine</surname> <given-names>A</given-names></name><name><surname>Raab</surname> <given-names>M</given-names></name><name><surname>Rudd</surname> <given-names>CE</given-names></name><name><surname>Schraven</surname> <given-names>B</given-names></name><name><surname>Neel</surname> <given-names>BG</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>SHPS-1 is a scaffold for assembling distinct adhesion-regulated multi-protein complexes in macrophages</article-title><source>Current Biology</source><volume>9</volume><fpage>927</fpage><lpage>S4</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(99)80401-1</pub-id><pub-id pub-id-type="pmid">10469599</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Togni</surname> <given-names>M</given-names></name><name><surname>Swanson</surname> <given-names>KD</given-names></name><name><surname>Reimann</surname> <given-names>S</given-names></name><name><surname>Kliche</surname> <given-names>S</given-names></name><name><surname>Pearce</surname> <given-names>AC</given-names></name><name><surname>Simeoni</surname> <given-names>L</given-names></name><name><surname>Reinhold</surname> <given-names>D</given-names></name><name><surname>Wienands</surname> <given-names>J</given-names></name><name><surname>Neel</surname> <given-names>BG</given-names></name><name><surname>Schraven</surname> <given-names>B</given-names></name><name><surname>Gerber</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Regulation of in vitro and in vivo immune functions by the cytosolic adaptor protein SKAP-HOM</article-title><source>Molecular and Cellular Biology</source><volume>25</volume><fpage>8052</fpage><lpage>8063</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.18.8052-8063.2005</pub-id><pub-id pub-id-type="pmid">16135797</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsang</surname> <given-names>E</given-names></name><name><surname>Giannetti</surname> <given-names>AM</given-names></name><name><surname>Shaw</surname> <given-names>D</given-names></name><name><surname>Dinh</surname> <given-names>M</given-names></name><name><surname>Tse</surname> <given-names>JK</given-names></name><name><surname>Gandhi</surname> <given-names>S</given-names></name><name><surname>Ho</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Papp</surname> <given-names>E</given-names></name><name><surname>Bradshaw</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Molecular mechanism of the syk activation switch</article-title><source>Journal of Biological Chemistry</source><volume>283</volume><fpage>32650</fpage><lpage>32659</lpage><pub-id pub-id-type="doi">10.1074/jbc.M806340200</pub-id><pub-id pub-id-type="pmid">18818202</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Ziffle</surname> <given-names>JA</given-names></name><name><surname>Lowell</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Neutrophil-specific deletion of syk kinase results in reduced host defense to bacterial infection</article-title><source>Blood</source><volume>114</volume><fpage>4871</fpage><lpage>4882</lpage><pub-id pub-id-type="doi">10.1182/blood-2009-05-220806</pub-id><pub-id pub-id-type="pmid">19797524</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volmering</surname> <given-names>S</given-names></name><name><surname>Block</surname> <given-names>H</given-names></name><name><surname>Boras</surname> <given-names>M</given-names></name><name><surname>Lowell</surname> <given-names>CA</given-names></name><name><surname>Zarbock</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The neutrophil btk signalosome regulates integrin activation during sterile inflammation</article-title><source>Immunity</source><volume>44</volume><fpage>73</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.11.011</pub-id><pub-id pub-id-type="pmid">26777396</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vornhagen</surname> <given-names>J</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Breen</surname> <given-names>P</given-names></name><name><surname>Forsyth</surname> <given-names>V</given-names></name><name><surname>Zhao</surname> <given-names>L</given-names></name><name><surname>Mobley</surname> <given-names>HLT</given-names></name><name><surname>Bachman</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The Klebsiella pneumoniae citrate synthase gene, gltA, influences site specific fitness during infection</article-title><source>PLOS Pathogens</source><volume>15</volume><elocation-id>e1008010</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008010</pub-id><pub-id pub-id-type="pmid">31449551</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname> <given-names>KA</given-names></name><name><surname>Miner</surname> <given-names>TA</given-names></name><name><surname>Palacios</surname> <given-names>M</given-names></name><name><surname>Trzilova</surname> <given-names>D</given-names></name><name><surname>Frederick</surname> <given-names>DR</given-names></name><name><surname>Broberg</surname> <given-names>CA</given-names></name><name><surname>Sepúlveda</surname> <given-names>VE</given-names></name><name><surname>Quinn</surname> <given-names>JD</given-names></name><name><surname>Miller</surname> <given-names>VL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A <italic>Klebsiella pneumoniae</italic> regulatory mutant has reduced capsule expression but retains hypermucoviscosity</article-title><source>mBio</source><volume>10</volume><elocation-id>e00089-19</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00089-19</pub-id><pub-id pub-id-type="pmid">30914502</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>GG</given-names></name><name><surname>Calvo</surname> <given-names>KR</given-names></name><name><surname>Pasillas</surname> <given-names>MP</given-names></name><name><surname>Sykes</surname> <given-names>DB</given-names></name><name><surname>Häcker</surname> <given-names>H</given-names></name><name><surname>Kamps</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8</article-title><source>Nature Methods</source><volume>3</volume><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1038/nmeth865</pub-id><pub-id pub-id-type="pmid">16554834</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Rudd</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>SKAP-55, SKAP-55-related and ADAP adaptors modulate integrin-mediated immune-cell adhesion</article-title><source>Trends in Cell Biology</source><volume>18</volume><fpage>486</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2008.07.005</pub-id><pub-id pub-id-type="pmid">18760924</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiner</surname> <given-names>LM</given-names></name><name><surname>Webb</surname> <given-names>AK</given-names></name><name><surname>Limbago</surname> <given-names>B</given-names></name><name><surname>Dudeck</surname> <given-names>MA</given-names></name><name><surname>Patel</surname> <given-names>J</given-names></name><name><surname>Kallen</surname> <given-names>AJ</given-names></name><name><surname>Edwards</surname> <given-names>JR</given-names></name><name><surname>Sievert</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Antimicrobial-Resistant pathogens associated with Healthcare-Associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011-2014</article-title><source>Infection Control &amp; Hospital Epidemiology</source><volume>37</volume><fpage>1288</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1017/ice.2016.174</pub-id><pub-id pub-id-type="pmid">27573805</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolach</surname> <given-names>B</given-names></name><name><surname>Gavrieli</surname> <given-names>R</given-names></name><name><surname>de Boer</surname> <given-names>M</given-names></name><name><surname>van Leeuwen</surname> <given-names>K</given-names></name><name><surname>Berger-Achituv</surname> <given-names>S</given-names></name><name><surname>Stauber</surname> <given-names>T</given-names></name><name><surname>Ben Ari</surname> <given-names>J</given-names></name><name><surname>Rottem</surname> <given-names>M</given-names></name><name><surname>Schlesinger</surname> <given-names>Y</given-names></name><name><surname>Grisaru-Soen</surname> <given-names>G</given-names></name><name><surname>Abuzaitoun</surname> <given-names>O</given-names></name><name><surname>Marcus</surname> <given-names>N</given-names></name><name><surname>Zion Garty</surname> <given-names>B</given-names></name><name><surname>Broides</surname> <given-names>A</given-names></name><name><surname>Levy</surname> <given-names>J</given-names></name><name><surname>Stepansky</surname> <given-names>P</given-names></name><name><surname>Etzioni</surname> <given-names>A</given-names></name><name><surname>Somech</surname> <given-names>R</given-names></name><name><surname>Roos</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Chronic granulomatous disease: clinical, functional, molecular, and genetic studies the israeli experience with 84 patients</article-title><source>American Journal of Hematology</source><volume>92</volume><fpage>28</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1002/ajh.24573</pub-id><pub-id pub-id-type="pmid">27701760</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname> <given-names>H</given-names></name><name><surname>Carter</surname> <given-names>RA</given-names></name><name><surname>Leiner</surname> <given-names>IM</given-names></name><name><surname>Tang</surname> <given-names>YW</given-names></name><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Kreiswirth</surname> <given-names>BN</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Distinct contributions of neutrophils and CCR2+ monocytes to pulmonary clearance of different Klebsiella pneumoniae strains</article-title><source>Infection and Immunity</source><volume>83</volume><fpage>3418</fpage><lpage>3427</lpage><pub-id pub-id-type="doi">10.1128/IAI.00678-15</pub-id><pub-id pub-id-type="pmid">26056382</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname> <given-names>H</given-names></name><name><surname>Keith</surname> <given-names>JW</given-names></name><name><surname>Samilo</surname> <given-names>DW</given-names></name><name><surname>Carter</surname> <given-names>RA</given-names></name><name><surname>Leiner</surname> <given-names>IM</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Innate lymphocyte/Ly6C(hi) Monocyte crosstalk promotes Klebsiella pneumoniae clearance</article-title><source>Cell</source><volume>165</volume><fpage>679</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.03.017</pub-id><pub-id pub-id-type="pmid">27040495</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>P</given-names></name><name><surname>Rodriguez</surname> <given-names>FH</given-names></name><name><surname>Kanaly</surname> <given-names>S</given-names></name><name><surname>Stocking</surname> <given-names>KL</given-names></name><name><surname>Schurr</surname> <given-names>J</given-names></name><name><surname>Schwarzenberger</surname> <given-names>P</given-names></name><name><surname>Oliver</surname> <given-names>P</given-names></name><name><surname>Huang</surname> <given-names>W</given-names></name><name><surname>Zhang</surname> <given-names>P</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Shellito</surname> <given-names>JE</given-names></name><name><surname>Bagby</surname> <given-names>GJ</given-names></name><name><surname>Nelson</surname> <given-names>S</given-names></name><name><surname>Charrier</surname> <given-names>K</given-names></name><name><surname>Peschon</surname> <given-names>JJ</given-names></name><name><surname>Kolls</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense</article-title><source>Journal of Experimental Medicine</source><volume>194</volume><fpage>519</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1084/jem.194.4.519</pub-id><pub-id pub-id-type="pmid">11514607</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarbock</surname> <given-names>A</given-names></name><name><surname>Lowell</surname> <given-names>CA</given-names></name><name><surname>Ley</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Spleen tyrosine kinase syk is necessary for E-selectin-induced αLβ2 integrin-mediated rolling on intercellular adhesion molecule-1</article-title><source>Immunity</source><volume>26</volume><fpage>773</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.04.011</pub-id><pub-id pub-id-type="pmid">17543554</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Zhao</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>Q</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>High prevalence of hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>60</volume><fpage>6115</fpage><lpage>6120</lpage><pub-id pub-id-type="doi">10.1128/AAC.01127-16</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Olonisakin</surname> <given-names>TF</given-names></name><name><surname>Xiong</surname> <given-names>Z</given-names></name><name><surname>Hulver</surname> <given-names>M</given-names></name><name><surname>Sayeed</surname> <given-names>S</given-names></name><name><surname>Yu</surname> <given-names>MT</given-names></name><name><surname>Gregory</surname> <given-names>AD</given-names></name><name><surname>Kochman</surname> <given-names>EJ</given-names></name><name><surname>Chen</surname> <given-names>BB</given-names></name><name><surname>Mallampalli</surname> <given-names>RK</given-names></name><name><surname>Sun</surname> <given-names>M</given-names></name><name><surname>Silverstein</surname> <given-names>RL</given-names></name><name><surname>Stolz</surname> <given-names>DB</given-names></name><name><surname>Shapiro</surname> <given-names>SD</given-names></name><name><surname>Ray</surname> <given-names>A</given-names></name><name><surname>Ray</surname> <given-names>P</given-names></name><name><surname>Lee</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Thrombospondin-1 restrains neutrophil granule serine protease function and regulates the innate immune response during Klebsiella pneumoniae infection</article-title><source>Mucosal Immunology</source><volume>8</volume><fpage>896</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1038/mi.2014.120</pub-id><pub-id pub-id-type="pmid">25492474</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>T</given-names></name><name><surname>Bokoch</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Critical role of proline-rich tyrosine kinase 2 in reversion of the adhesion-mediated suppression of reactive oxygen species generation by human neutrophils</article-title><source>The Journal of Immunology</source><volume>174</volume><fpage>8049</fpage><lpage>8055</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.174.12.8049</pub-id><pub-id pub-id-type="pmid">15944312</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>J</given-names></name><name><surname>Zhou</surname> <given-names>K</given-names></name><name><surname>Jiang</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Bai</surname> <given-names>H</given-names></name><name><surname>Jiang</surname> <given-names>J</given-names></name><name><surname>Gao</surname> <given-names>Y</given-names></name><name><surname>Cai</surname> <given-names>Q</given-names></name><name><surname>Tong</surname> <given-names>Y</given-names></name><name><surname>Song</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Wan</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Bacterial pathogens differed between neutropenic and Non-neutropenic patients in the same hematological ward: an 8-Year survey</article-title><source>Clinical Infectious Diseases</source><volume>67</volume><fpage>S174</fpage><lpage>S178</lpage><pub-id pub-id-type="doi">10.1093/cid/ciy643</pub-id><pub-id pub-id-type="pmid">30423039</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.56656.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Stallings</surname><given-names>Christina L</given-names></name><role>Reviewing Editor</role><aff><institution>Washington University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>DeLeo</surname><given-names>Frank</given-names> </name><role>Reviewer</role><aff><institution>NIH</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Rosen</surname><given-names>David</given-names> </name><role>Reviewer</role><aff><institution>Washington University in St. Louis</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Your investigations into the role of SKAP2 in immune defense against <italic>Klebsiellapneumoniae</italic>, including the elegant integration of in vivo and cell culture approaches to dissect a potential mechanistic basis for SKAP2-mediated host defense, will certainly be of interest to our readers and we are thrilled to accept it for publication.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;SKAP-2 is required for neutrophil respiratory burst in response to <italic>Klebsiella</italic> infection&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Jos van der Meer as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Frank DeLeo (Reviewer #1); David Rosen (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as <italic>eLife</italic> papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity and presentation.</p><p>All three reviewers were very positive about the manuscript. The findings are interesting and important, however there are some concerns that some conclusions are overstated and more information in required in parts. In addition, context for some of the reagents and methods would be helpful for the broad readership of <italic>eLife</italic>. The reviewers believe that these revisions should be able to be done without additional experiments.</p><p>Major Comments:</p><p>1) The authors focus on the conclusion that they show a role for SKAP2 in neutrophils, which, based on their data is true in vitro. However, the data presented falls short of showing that this is related to the phenotypes observed in vivo. Figure 2 shows that loss of SKAP2 in hematopoetic cells is responsible for the susceptibility phenotype and that neutrophils contribute to control of this particular <italic>Klebsiella</italic> strain in WT mice. But the data do not show that SKAP2 has a role in neutrophils in vivo during infection, it only shows that neutrophils cannot control the infection in the absence of SKAP2 in the hematopoetic compartment. Therefore, without additional data (i.e. specific deletion in neutrophils or transferring of purified neutrophils from a knockout into a WT (or vice versa) or using a <italic>Klebsiella</italic> strain not reliant on neutrophils for control of infection), the authors need to change their conclusions to more accurately match the data shown throughout the manuscript.</p><p>2) The flow cytometry data should also be presented as number of cells in a population (in addition to frequency of a population). For the flow cytometry data throughout the paper, the authors show % of live cells.</p><p>3) It would be optimal if the authors had some data that shows a similar function for SKAP2 in human neutrophils. At the very least, text should be included that acknowledges the caveats (well known) of extrapolating data from mouse neutrophils to human neutrophils. The authors should be cautious in extrapolating their data to additional scenarios beyond those tested.</p><p>4) In Discussion paragraph four the authors mentioned published work that <italic>SKAP2-/-</italic> neutrophils exhibit a migration defect in response to sterile inflammation and imply there is no migration defect during infection. But the authors never show any data to support this implication. The authors assume that migration kinetics are the same because they measure the same number of neutrophils in the lungs during infection at specific timepoints, but they do not provide information on how many neutrophils were present in the blood and lungs of naïve mice, nor do they do a pulse labeling of newly differentiated neutrophils to track their rate of migration.</p><p>5) In this same section, the authors mention that neutrophil survival could be affected by loss of SKAP2. This is a very important point in general and in particular for when analyzing their in vitro data. Did the authors observe a difference in survival of neutrophils from SKAP2 mice? How were each of their in vitro studies normalized for total live cells at each time point?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.56656.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Major Comments:</p><p>1) The authors focus on the conclusion that they show a role for SKAP2 in neutrophils, which, based on their data is true in vitro. However, the data presented falls short of showing that this is related to the phenotypes observed in vivo. Figure 2 shows that loss of SKAP2 in hematopoetic cells is responsible for the susceptibility phenotype and that neutrophils contribute to control of this particular Klebsiella strain in WT mice. But the data do not show that SKAP2 has a role in neutrophils in vivo during infection, it only shows that neutrophils cannot control the infection in the absence of SKAP2 in the hematopoetic compartment. Therefore, without additional data (i.e. specific deletion in neutrophils or transferring of purified neutrophils from a knockout into a WT (or vice versa) or using a Klebsiella strain not reliant on neutrophils for control of infection), the authors need to change their conclusions to more accurately match the data shown throughout the manuscript.</p></disp-quote><p>The reviewers make an excellent point. We have not done those specific experiments. Therefore, this conclusion has been modified throughout the manuscript.</p><disp-quote content-type="editor-comment"><p>2) The flow cytometry data should also be presented as number of cells in a population (in addition to frequency of a population). For the flow cytometry data throughout the paper, the authors show % of live cells.</p></disp-quote><p>We thank the reviewers for the suggestion. All flow cytometry data are now presented as frequency and number of cells in a population.</p><disp-quote content-type="editor-comment"><p>3) It would be optimal if the authors had some data that shows a similar function for SKAP2 in human neutrophils. At the very least, text should be included that acknowledges the caveats (well known) of extrapolating data from mouse neutrophils to human neutrophils. The authors should be cautious in extrapolating their data to additional scenarios beyond those tested.</p></disp-quote><p>We agree with reviewers that such data would be great and is a key next step regarding whether there are differences between mouse and human immune response to <italic>K. pneumoniae</italic> infection, their ROS response, and the activation of various signal transduction pathways. We now discuss the caveats of using murine models to study <italic>K. pneumoniae</italic> in paragraph four of the Discussion, and cited specific references that are relevant to immune components investigated in our study. In addition, we have clarified that our data and proposed model is limited to murine studies throughout our manuscript.</p><p>Currently, to our knowledge, there are no commercially available inhibitors of Skap2 or its homologs. However, we note in the Introduction and Discussion sections that in addition to those associated with Crohn’s disease and Type I diabetes, there are other reported variants in Skap2 genes in humans in the Ensembl database (http://useast.ensembl.org/Homo_sapiens/Gene/Variation_Gene/Table?db=core;g=ENSG00000005020;r=7:26667068-26995239) although their functional phenotype is unknown. Thus, in the absence of other advances to genetically manipulate human hemopoietic stem cells and differentiate these into PMNs (or using HL-60 cells), future studies evaluating SKAP2 in human neutrophils will require isolating them from these individuals.</p><disp-quote content-type="editor-comment"><p>4) In Discussion paragraph four the authors mentioned published work that SKAP2-/- neutrophils exhibit a migration defect in response to sterile inflammation and imply there is no migration defect during infection. But the authors never show any data to support this implication. The authors assume that migration kinetics are the same because they measure the same number of neutrophils in the lungs during infection at specific timepoints, but they do not provide information on how many neutrophils were present in the blood and lungs of naïve mice, nor do they do a pulse labeling of newly differentiated neutrophils to track their rate of migration.</p></disp-quote><p>We agree. To provide more data about the levels of neutrophils in these mice, we have now included the frequency and number of neutrophils were present in the bone marrow naïve mice (Figure 1—figure supplement 1B-C), and cited a prior publication comparing the level of neutrophils present in the blood of naïve mice (Togni et al., 2005). In addition, we have clarified the level of neutrophils in PBS-treated lungs in Figure 1C and Figure 1—figure supplement 1A; levels of alveolar macrophages, dendritic cells, and resident monocytes from PBS-treated lungs are shown as dotted line in Figure 1—figure supplement 1E-J. We have also included preliminary data in the number of neutrophils recovered from the bronchoalveolar lavage of infected mice at 16 and 24 hours in Figure 1—figure supplement 1D. In all cases, there are no differences between the two strains of mice. However, as the reviewers point out these data do not prove that the migration kinetics are the same, and that a pulse labeling of newly differentiated neutrophils will be optimal in addressing this question. We have included this point in the Discussion.</p><disp-quote content-type="editor-comment"><p>5) In this same section, the authors mention that neutrophil survival could be affected by loss of SKAP2. This is a very important point in general and in particular for when analyzing their in vitro data. Did the authors observe a difference in survival of neutrophils from SKAP2 mice? How were each of their in vitro studies normalized for total live cells at each time point?</p></disp-quote><p>The viability of neutrophils collected for in vitro studies was assessed by trypan blue exclusion test during cell counting by hemocytometer immediately prior to aliquoting the neutrophils into assay conditions (subsection “Differentiating neutrophils from Hoxb8-immortalized stem cell lines”). The number of cells used per condition was based on the number of trypan blue excluded cells prior to functional studies. We have now included a sample of viability based on this assay for DIV neutrophils differentiated from 2 sets of Hoxb8 GMP (where GMP were harvested from different mice on different day) in Figure 3—figure supplement 1E. In some experiments, we also used Promega CellTiter-Glo Luminescent Cell viability assay to track neutrophil survival through the ATP measurement through the course of our functional studies; an example is shown in Figure 3—figure supplement 1F on unstimulated neutrophils, which was taken alongside a ROS assay.</p></body></sub-article></article>